Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 39 | 0 | 0 | 39 |
thioredoxin reductase | 45 | 0 | 0 | 45 |
ATAD5 protein, partial | 19 | 0 | 0 | 19 |
GLS protein | 26 | 0 | 0 | 26 |
TDP1 protein | 61 | 0 | 0 | 61 |
regulator of G-protein signaling 4 | 24 | 0 | 0 | 24 |
67.9K protein | 15 | 0 | 0 | 15 |
Parkin | 7 | 0 | 0 | 7 |
bromodomain adjacent to zinc finger domain 2B | 15 | 0 | 0 | 15 |
IDH1 | 17 | 0 | 0 | 17 |
euchromatic histone-lysine N-methyltransferase 2 | 65 | 0 | 0 | 65 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 15 | 0 | 0 | 15 |
huntingtin isoform 2 | 9 | 0 | 0 | 9 |
ras-related protein Rab-9A | 8 | 0 | 0 | 8 |
serine/threonine-protein kinase mTOR isoform 1 | 7 | 0 | 0 | 7 |
urokinase-type plasminogen activator precursor | 9 | 0 | 0 | 9 |
plasminogen precursor | 9 | 0 | 0 | 9 |
urokinase plasminogen activator surface receptor precursor | 9 | 0 | 0 | 9 |
survival motor neuron protein isoform d | 25 | 0 | 0 | 25 |
D(1A) dopamine receptor | 6 | 0 | 0 | 6 |
Ataxin-2 | 24 | 0 | 0 | 24 |
ATP-dependent phosphofructokinase | 27 | 0 | 0 | 27 |
aldehyde dehydrogenase 1 family, member A1 | 53 | 0 | 0 | 53 |
retinoic acid nuclear receptor alpha variant 1 | 57 | 0 | 0 | 57 |
peroxisome proliferator activated receptor gamma | 48 | 0 | 0 | 48 |
chromobox protein homolog 1 | 44 | 0 | 0 | 44 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 58 | 0 | 0 | 58 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 30 | 0 | 0 | 30 |
Chain A, 2-oxoglutarate Oxygenase | 40 | 0 | 0 | 40 |
Chain A, Cruzipain | 17 | 0 | 0 | 17 |
15-lipoxygenase, partial | 16 | 0 | 0 | 16 |
phosphopantetheinyl transferase | 34 | 0 | 0 | 34 |
USP1 protein, partial | 35 | 0 | 0 | 35 |
thyroid stimulating hormone receptor | 33 | 0 | 0 | 33 |
polyunsaturated fatty acid lipoxygenase ALOX12 | 6 | 0 | 0 | 6 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 26 | 0 | 0 | 26 |
vitamin D3 receptor isoform VDRA | 28 | 0 | 0 | 28 |
thyroid hormone receptor beta isoform a | 33 | 0 | 0 | 33 |
mitogen-activated protein kinase 1 | 19 | 0 | 0 | 19 |
nuclear receptor ROR-gamma isoform 1 | 21 | 0 | 0 | 21 |
cytochrome P450 3A4 isoform 1 | 36 | 0 | 0 | 36 |
histone acetyltransferase KAT2A isoform 1 | 23 | 0 | 0 | 23 |
lethal factor (plasmid) | 19 | 0 | 0 | 19 |
Gamma-aminobutyric acid receptor subunit pi | 36 | 2 | 1 | 39 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 12 | 1 | 0 | 13 |
Transient receptor potential cation channel subfamily M member 2 | 0 | 1 | 0 | 1 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 7 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit beta-1 | 36 | 2 | 1 | 39 |
Gamma-aminobutyric acid receptor subunit delta | 36 | 2 | 1 | 39 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 36 | 2 | 1 | 39 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 36 | 2 | 1 | 39 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 36 | 2 | 1 | 39 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 36 | 2 | 1 | 39 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 36 | 2 | 1 | 39 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 36 | 2 | 1 | 39 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 36 | 2 | 1 | 39 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 36 | 2 | 1 | 39 |
Histamine H2 receptor | 21 | 0 | 2 | 23 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 36 | 3 | 1 | 40 |
Gamma-aminobutyric acid receptor subunit beta-3 | 36 | 2 | 1 | 39 |
Gamma-aminobutyric acid receptor subunit beta-2 | 36 | 2 | 1 | 39 |
Transient receptor potential cation channel subfamily V member 1 | 0 | 0 | 1 | 2 |
Transient receptor potential cation channel subfamily V member 3 | 0 | 0 | 0 | 1 |
GABA theta subunit | 36 | 2 | 1 | 39 |
Gamma-aminobutyric acid receptor subunit epsilon | 36 | 2 | 1 | 39 |
Transient receptor potential cation channel subfamily V member 2 | 0 | 0 | 0 | 1 |
Luciferase | 27 | 0 | 0 | 27 |
SMAD family member 2 | 25 | 0 | 0 | 25 |
SMAD family member 3 | 25 | 0 | 0 | 25 |
AR protein | 74 | 0 | 0 | 74 |
progesterone receptor | 40 | 0 | 0 | 40 |
retinoid X nuclear receptor alpha | 50 | 0 | 0 | 50 |
estrogen-related nuclear receptor alpha | 64 | 0 | 0 | 64 |
estrogen nuclear receptor alpha | 82 | 0 | 0 | 82 |
peroxisome proliferator-activated receptor delta | 44 | 0 | 0 | 44 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 39 | 0 | 0 | 39 |
thyroid hormone receptor beta isoform 2 | 50 | 0 | 0 | 50 |
serine/threonine-protein kinase PLK1 | 6 | 0 | 0 | 6 |
Pyruvate dehydrogenase E1 component subunit alpha, mitochondrial | 0 | 1 | 0 | 1 |
Pyruvate dehydrogenase E1 component subunit beta, mitochondrial | 0 | 1 | 0 | 1 |
Guanine nucleotide-binding protein G | 11 | 0 | 0 | 11 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 17 | 0 | 0 | 17 |
farnesoid X nuclear receptor | 33 | 0 | 0 | 33 |
pregnane X nuclear receptor | 49 | 0 | 0 | 49 |
Androgen receptor | 0 | 13 | 1 | 15 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, HADH2 protein | 35 | 0 | 0 | 35 |
Chain B, HADH2 protein | 35 | 0 | 0 | 35 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 12 | 0 | 0 | 12 |
Chain A, Protocatechuate 3,4-dioxygenase | 0 | 0 | 1 | 1 |
Chain M, Protocatechuate 3,4-dioxygenase | 0 | 0 | 1 | 1 |
Olfactory receptor class A-like protein 1 | 0 | 0 | 1 | 1 |
endonuclease IV | 5 | 0 | 0 | 5 |
RGS12 | 1 | 0 | 0 | 1 |
NFKB1 protein, partial | 12 | 0 | 0 | 12 |
Microtubule-associated protein tau | 37 | 0 | 0 | 37 |
Thrombopoietin | 11 | 0 | 0 | 11 |
alkaline phosphatase, intestinal | 0 | 1 | 1 | 2 |
thioredoxin glutathione reductase | 15 | 0 | 0 | 15 |
apical membrane antigen 1, AMA1 | 12 | 0 | 0 | 12 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 16 | 0 | 0 | 16 |
hypothetical protein, conserved | 4 | 0 | 0 | 4 |
Bloom syndrome protein isoform 1 | 32 | 0 | 0 | 32 |
lysosomal alpha-glucosidase preproprotein | 9 | 0 | 0 | 9 |
peripheral myelin protein 22 isoform 1 | 19 | 0 | 0 | 19 |
alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein | 0 | 2 | 0 | 2 |
intestinal alkaline phosphatase precursor | 0 | 2 | 0 | 2 |
guanine nucleotide-binding protein G(i) subunit alpha-1 isoform 1 | 1 | 0 | 0 | 1 |
DNA polymerase beta | 10 | 0 | 0 | 10 |
flap endonuclease 1 | 19 | 0 | 0 | 19 |
DNA polymerase iota isoform a (long) | 26 | 0 | 0 | 26 |
geminin | 65 | 0 | 0 | 65 |
M-phase phosphoprotein 8 | 16 | 0 | 0 | 16 |
alkaline phosphatase, germ cell type preproprotein | 0 | 1 | 1 | 2 |
POsterior Segregation | 0 | 0 | 2 | 2 |
muscarinic acetylcholine receptor M1 | 17 | 0 | 0 | 17 |
lamin isoform A-delta10 | 53 | 0 | 0 | 53 |
Prolyl 4-hydroxylase subunit alpha-1 | 0 | 2 | 0 | 2 |
Sodium-dependent noradrenaline transporter | 0 | 4 | 2 | 6 |
Zinc finger protein mex-5 | 0 | 0 | 2 | 2 |
Chain A, Ferritin light chain | 14 | 0 | 0 | 14 |
acetylcholinesterase | 22 | 0 | 0 | 22 |
hypoxia-inducible factor 1 alpha subunit | 22 | 0 | 0 | 22 |
RAR-related orphan receptor gamma | 59 | 0 | 0 | 59 |
GLI family zinc finger 3 | 54 | 0 | 0 | 54 |
caspase 7, apoptosis-related cysteine protease | 12 | 0 | 0 | 12 |
estrogen receptor 2 (ER beta) | 30 | 0 | 0 | 30 |
nuclear receptor subfamily 1, group I, member 3 | 43 | 0 | 0 | 43 |
glucocorticoid receptor [Homo sapiens] | 52 | 0 | 0 | 52 |
caspase-3 | 12 | 0 | 0 | 12 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 36 | 0 | 0 | 36 |
activating transcription factor 6 | 29 | 0 | 0 | 29 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 20 | 0 | 0 | 20 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 34 | 0 | 0 | 34 |
Histone H2A.x | 25 | 0 | 0 | 25 |
Caspase-7 | 8 | 0 | 0 | 8 |
cellular tumor antigen p53 isoform a | 20 | 0 | 0 | 20 |
potassium voltage-gated channel subfamily H member 2 isoform d | 20 | 0 | 0 | 20 |
caspase-3 | 8 | 0 | 0 | 8 |
heat shock protein beta-1 | 18 | 0 | 0 | 18 |
nuclear factor NF-kappa-B p105 subunit isoform 1 | 7 | 0 | 0 | 7 |
5-hydroxytryptamine receptor 4 | 0 | 6 | 0 | 6 |
Voltage-dependent calcium channel gamma-2 subunit | 25 | 0 | 0 | 25 |
Estrogen receptor | 0 | 6 | 1 | 7 |
Sex hormone-binding globulin | 0 | 1 | 8 | 9 |
Cellular tumor antigen p53 | 52 | 0 | 0 | 52 |
Aldo-keto reductase family 1 member B1 | 0 | 6 | 0 | 6 |
Alpha-2A adrenergic receptor | 0 | 6 | 1 | 7 |
60 kDa chaperonin | 0 | 8 | 0 | 8 |
Adenosine receptor A3 | 0 | 7 | 0 | 7 |
60 kDa heat shock protein, mitochondrial | 0 | 8 | 0 | 8 |
Beta-3 adrenergic receptor | 0 | 3 | 1 | 4 |
Alpha-1B adrenergic receptor | 0 | 12 | 0 | 12 |
Sulfotransferase 1A1 | 0 | 0 | 0 | 2 |
Glutamate receptor 2 | 26 | 3 | 1 | 30 |
Substance-K receptor | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 2C | 0 | 6 | 0 | 6 |
Sodium-dependent serotonin transporter | 0 | 6 | 0 | 6 |
Alpha-1A adrenergic receptor | 0 | 12 | 0 | 12 |
Nuclear receptor ROR-gamma | 20 | 1 | 1 | 22 |
10 kDa heat shock protein, mitochondrial | 0 | 8 | 0 | 8 |
Sodium-dependent dopamine transporter | 0 | 4 | 0 | 4 |
Thiosulfate sulfurtransferase | 0 | 8 | 0 | 8 |
60 kDa chaperonin | 0 | 8 | 0 | 8 |
10 kDa chaperonin | 0 | 8 | 0 | 8 |
Solute carrier organic anion transporter family member 2A1 | 0 | 0 | 0 | 3 |
ERAP1 protein | 0 | 0 | 0 | 1 |
glucocerebrosidase | 9 | 0 | 0 | 9 |
alpha-galactosidase | 7 | 0 | 0 | 7 |
importin subunit beta-1 isoform 1 | 7 | 0 | 0 | 7 |
snurportin-1 | 7 | 0 | 0 | 7 |
caspase-1 isoform alpha precursor | 9 | 0 | 0 | 9 |
Acetylcholinesterase | 0 | 8 | 0 | 9 |
Polyphenol oxidase 2 | 0 | 6 | 0 | 9 |
Carbonic anhydrase 12 | 0 | 8 | 0 | 15 |
Carbonic anhydrase 1 | 0 | 25 | 0 | 37 |
Carbonic anhydrase 2 | 0 | 26 | 1 | 40 |
Glyceraldehyde-3-phosphate dehydrogenase | 0 | 2 | 0 | 2 |
Seed linoleate 13S-lipoxygenase-1 | 0 | 6 | 0 | 10 |
Tyrosinase | 0 | 4 | 0 | 4 |
Aldo-keto reductase family 1 member B1 | 0 | 11 | 0 | 11 |
Acetylcholinesterase | 0 | 14 | 0 | 15 |
Glyceraldehyde-3-phosphate dehydrogenase, glycosomal | 0 | 3 | 0 | 3 |
Genome polyprotein | 0 | 1 | 0 | 1 |
Substance-P receptor | 0 | 4 | 0 | 6 |
Quinone oxidoreductase | 0 | 0 | 0 | 2 |
Xanthine dehydrogenase/oxidase | 0 | 7 | 0 | 7 |
Caspase-7 | 8 | 0 | 0 | 8 |
Beta-secretase 1 | 0 | 8 | 0 | 8 |
Small conductance calcium-activated potassium channel protein 3 | 0 | 1 | 0 | 1 |
Cholinesterase | 0 | 6 | 0 | 7 |
Sorbitol dehydrogenase | 0 | 3 | 0 | 3 |
Induced myeloid leukemia cell differentiation protein Mcl-1 | 0 | 7 | 1 | 8 |
Carbonic anhydrase 9 | 0 | 10 | 0 | 17 |
Zn finger protein | 0 | 2 | 0 | 2 |
Dihydroorotate dehydrogenase | 0 | 3 | 0 | 3 |
Chain A, Avidin | 0 | 0 | 2 | 2 |
Chain A, Avidin | 0 | 0 | 2 | 2 |
Chain B, Avidin | 0 | 0 | 2 | 2 |
Olfactory receptor 51E2 | 0 | 0 | 3 | 3 |
Smad3 | 17 | 0 | 0 | 17 |
EWS/FLI fusion protein | 25 | 0 | 0 | 26 |
aryl hydrocarbon receptor | 23 | 0 | 0 | 23 |
peripheral myelin protein 22 | 35 | 0 | 0 | 35 |
ATP-binding cassette sub-family C member 3 | 0 | 26 | 0 | 26 |
Multidrug resistance-associated protein 4 | 0 | 26 | 0 | 29 |
Solute carrier family 22 member 6 | 0 | 7 | 0 | 8 |
UDP-glucuronosyltransferase 1A9 | 0 | 0 | 0 | 1 |
Bile salt export pump | 0 | 14 | 0 | 14 |
Bile salt export pump | 0 | 45 | 0 | 45 |
Cytochrome P450 2B1 | 0 | 0 | 0 | 1 |
Cytochrome P450 1A1 | 0 | 0 | 0 | 1 |
Myoglobin | 0 | 1 | 0 | 1 |
Cytochrome P450 1A1 | 0 | 5 | 2 | 8 |
Cytochrome P450 1A2 | 0 | 5 | 2 | 9 |
Prostaglandin G/H synthase 1 | 0 | 7 | 1 | 8 |
Carbonic anhydrase 3 | 0 | 5 | 0 | 9 |
Cytochrome P450 3A4 | 0 | 10 | 4 | 17 |
Cytochrome P450 2D6 | 0 | 10 | 2 | 12 |
Cytochrome P450 2C9 | 0 | 14 | 3 | 18 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 4 | 0 | 4 |
UDP-glucuronosyltransferase 1-6 | 0 | 1 | 0 | 2 |
Arachidonate 5-lipoxygenase-activating protein | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A1 | 0 | 2 | 0 | 3 |
Carbonic anhydrase 4 | 0 | 16 | 0 | 21 |
Prostaglandin G/H synthase 1 | 0 | 9 | 0 | 9 |
Carbonic anhydrase 6 | 0 | 7 | 0 | 12 |
Carbonic anhydrase 5A, mitochondrial | 0 | 7 | 0 | 12 |
Prostaglandin G/H synthase 2 | 0 | 13 | 1 | 16 |
Carbonic anhydrase 7 | 0 | 6 | 0 | 11 |
Cytochrome P450 2J2 | 0 | 9 | 0 | 9 |
Canalicular multispecific organic anion transporter 1 | 0 | 21 | 0 | 22 |
Carbonic anhydrase 15 | 0 | 9 | 0 | 13 |
Carbonic anhydrase 13 | 0 | 5 | 0 | 9 |
Carbonic anhydrase 14 | 0 | 5 | 0 | 10 |
Carbonic anhydrase 5B, mitochondrial | 0 | 5 | 0 | 10 |
toxin B | 0 | 0 | 0 | 1 |
Free fatty acid receptor 3 | 0 | 0 | 1 | 1 |
Free fatty acid receptor 2 | 0 | 1 | 1 | 2 |
Tyrosine-protein kinase Lck | 0 | 1 | 1 | 2 |
Tyrosine-protein kinase Fyn | 0 | 2 | 1 | 3 |
Fibrinogen C domain-containing protein 1 | 0 | 1 | 0 | 1 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 14 | 0 | 0 | 14 |
dopamine D1 receptor | 2 | 0 | 0 | 2 |
pregnane X receptor | 16 | 0 | 0 | 16 |
arylsulfatase A | 16 | 0 | 0 | 16 |
D(1A) dopamine receptor | 8 | 0 | 0 | 8 |
Histone deacetylase 3 | 0 | 4 | 0 | 4 |
Histone deacetylase 4 | 0 | 3 | 0 | 3 |
Histone deacetylase 1 | 0 | 6 | 0 | 6 |
Histone deacetylase 7 | 0 | 3 | 0 | 3 |
Histone deacetylase 2 | 0 | 6 | 0 | 6 |
Polyamine deacetylase HDAC10 | 0 | 2 | 0 | 2 |
Histone deacetylase 11 | 0 | 3 | 0 | 3 |
Histone deacetylase 8 | 0 | 4 | 0 | 4 |
Histone deacetylase 6 | 0 | 4 | 0 | 4 |
Histone deacetylase 9 | 0 | 2 | 0 | 2 |
Histone deacetylase 5 | 0 | 3 | 0 | 3 |
Chain A, Heat Shock Protein 90 | 0 | 0 | 1 | 1 |
Chain A, GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE | 0 | 0 | 1 | 1 |
Chain B, GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE | 0 | 0 | 1 | 1 |
Chain A, EOSINOPHIL-DERIVED NEUROTOXIN | 0 | 1 | 0 | 1 |
Chain A, EOSINOPHIL-DERIVED NEUROTOXIN | 0 | 1 | 0 | 1 |
Chain A, EOSINOPHIL-DERIVED NEUROTOXIN | 0 | 1 | 0 | 1 |
Chain A, Myosin Ie Heavy Chain | 0 | 0 | 1 | 1 |
Chain A, Preprotein translocase secA | 0 | 0 | 1 | 1 |
Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
Chain A, Phosphoribosylformylglycinamidine synthase | 0 | 1 | 0 | 1 |
Chain A, nucleoside diphosphate kinase A | 0 | 0 | 1 | 1 |
Chain B, nucleoside diphosphate kinase A | 0 | 0 | 1 | 1 |
Chain D, DNA polymerase III subunit gamma | 0 | 0 | 1 | 1 |
Chain D, DNA polymerase III subunit gamma | 0 | 0 | 1 | 1 |
Chain A [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3 | 0 | 0 | 1 | 1 |
Chain A [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3 | 0 | 0 | 1 | 1 |
Chain A, Kinesin-like protein KIF11 | 0 | 1 | 0 | 1 |
HPr kinase/phosphorylase | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase kinase kinase 7 | 0 | 0 | 1 | 1 |
ATP-dependent molecular chaperone HSP82 | 0 | 0 | 0 | 1 |
Heat shock protein HSP 90-alpha | 0 | 1 | 1 | 3 |
Heat shock protein HSP 90-beta | 0 | 2 | 1 | 4 |
2-dehydropantoate 2-reductase | 0 | 1 | 1 | 2 |
Heat shock 70 kDa protein 1A | 0 | 1 | 1 | 2 |
Endoplasmic reticulum chaperone BiP | 0 | 0 | 1 | 1 |
Heat shock cognate 71 kDa protein | 0 | 0 | 1 | 1 |
Pyruvate kinase PKM | 0 | 0 | 0 | 1 |
Pyruvate kinase PKLR | 0 | 0 | 0 | 1 |
Endoplasmin | 0 | 0 | 0 | 1 |
Heat shock cognate 71 kDa protein | 0 | 0 | 1 | 1 |
5'-nucleotidase | 0 | 2 | 0 | 2 |
Mu-type opioid receptor | 0 | 6 | 3 | 12 |
Delta-type opioid receptor | 0 | 6 | 3 | 12 |
Kappa-type opioid receptor | 0 | 6 | 4 | 13 |
Endoplasmin | 0 | 1 | 1 | 2 |
P2Y purinoceptor 2 | 0 | 0 | 1 | 1 |
Phosphatidylinositol 4-kinase alpha | 0 | 2 | 0 | 2 |
P2X purinoceptor 1 | 0 | 0 | 1 | 1 |
P2Y purinoceptor 1 | 0 | 0 | 1 | 1 |
P2Y purinoceptor 1 | 0 | 0 | 1 | 1 |
P2X purinoceptor 1 | 0 | 0 | 1 | 1 |
P2X purinoceptor 4 | 0 | 0 | 1 | 1 |
P2X purinoceptor 5 | 0 | 0 | 1 | 1 |
P2X purinoceptor 6 | 0 | 0 | 1 | 1 |
P2X purinoceptor 3 | 0 | 0 | 1 | 1 |
Inositol monophosphatase 1 | 10 | 0 | 0 | 10 |
Heat shock protein 75 kDa, mitochondrial | 0 | 1 | 0 | 1 |
P2Y purinoceptor 6 | 0 | 0 | 1 | 1 |
Phosphatidylinositol 4-kinase type 2-beta | 0 | 2 | 0 | 2 |
P2Y purinoceptor 11 | 0 | 0 | 1 | 1 |
Phosphatidylinositol 4-kinase type 2-alpha | 0 | 2 | 0 | 2 |
P2Y purinoceptor 12 | 0 | 1 | 1 | 2 |
Sensor protein kinase WalK | 0 | 1 | 0 | 1 |
Phosphatidylinositol 4-kinase beta | 0 | 2 | 0 | 2 |
P2X purinoceptor 2 | 0 | 0 | 1 | 1 |
Acetylcholinesterase | 0 | 4 | 0 | 4 |
Alanine racemase, biosynthetic | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 1D | 0 | 0 | 0 | 4 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 9 | 3 | 16 |
Proton-coupled amino acid transporter 1 | 0 | 6 | 0 | 6 |
Adenosine deaminase | 0 | 0 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 0 | 0 | 4 |
Corticosteroid-binding globulin | 0 | 8 | 0 | 8 |
Mineralocorticoid receptor | 0 | 6 | 4 | 11 |
Mineralocorticoid receptor | 0 | 2 | 0 | 2 |
Solute carrier organic anion transporter family member 1A1 | 0 | 2 | 0 | 3 |
Chain U, UROKINASE-TYPE PLASMINOGEN ACTIVATOR | 0 | 1 | 0 | 1 |
Chain A, UROKINASE-TYPE PLASMINOGEN ACTIVATOR | 0 | 1 | 0 | 1 |
Chain A, UROKINASE-TYPE PLASMINOGEN ACTIVATOR | 0 | 1 | 0 | 1 |
acid sphingomyelinase | 5 | 0 | 0 | 5 |
cytochrome P450 2D6 isoform 1 | 12 | 0 | 0 | 12 |
cytochrome P450 2C19 precursor | 15 | 0 | 0 | 15 |
Membrane primary amine oxidase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 11 | 0 | 16 |
Prothrombin | 0 | 4 | 4 | 8 |
Coagulation factor X | 0 | 1 | 0 | 1 |
Plasminogen | 0 | 1 | 0 | 1 |
Urokinase-type plasminogen activator | 0 | 4 | 0 | 4 |
Tissue-type plasminogen activator | 0 | 3 | 0 | 3 |
Cationic trypsin | 0 | 3 | 0 | 3 |
Coagulation factor XI | 0 | 1 | 0 | 1 |
Plasma kallikrein | 0 | 2 | 0 | 6 |
Vitamin K-dependent protein C | 0 | 1 | 0 | 1 |
Urokinase-type plasminogen activator | 0 | 3 | 0 | 3 |
Trypsin-1 | 0 | 2 | 0 | 2 |
Trypsin-2 | 0 | 2 | 0 | 2 |
Sodium/hydrogen exchanger 1 | 0 | 2 | 0 | 2 |
Amine oxidase [flavin-containing] A | 0 | 7 | 0 | 7 |
Sodium/hydrogen exchanger 1 | 0 | 4 | 0 | 4 |
Sodium/hydrogen exchanger 3 | 0 | 4 | 0 | 4 |
Adenosine receptor A2a | 0 | 2 | 0 | 2 |
Trypsin-3 | 0 | 2 | 0 | 2 |
Amiloride-sensitive sodium channel subunit alpha | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 7 | 0 | 8 |
Sodium/hydrogen exchanger 2 | 0 | 4 | 0 | 4 |
Acid-sensing ion channel 1 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 12 | 0 | 12 |
Sodium channel protein type 5 subunit alpha | 0 | 5 | 0 | 5 |
Sodium/hydrogen exchanger 5 | 0 | 4 | 0 | 4 |
Solute carrier family 22 member 1 | 0 | 7 | 0 | 9 |
Solute carrier family 22 member 2 | 0 | 7 | 0 | 9 |
Acid-sensing ion channel 3 | 0 | 1 | 0 | 1 |
Sodium/hydrogen exchanger | 0 | 2 | 0 | 2 |
Chain A, Beta-lactamase | 17 | 0 | 0 | 17 |
Gamma-aminobutyric acid receptor subunit rho-1 | 0 | 1 | 0 | 1 |
Glutamate receptor 1 | 0 | 3 | 1 | 4 |
Glutamate receptor 2 | 0 | 3 | 1 | 4 |
Glutamate receptor 3 | 0 | 2 | 1 | 3 |
Glutamate receptor ionotropic, kainate 3 | 0 | 3 | 0 | 3 |
Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
Glutamate receptor 4 | 0 | 3 | 1 | 4 |
Solute carrier family 15 member 1 | 0 | 3 | 0 | 3 |
Solute carrier family 15 member 2 | 0 | 2 | 0 | 2 |
interleukin 8 | 16 | 0 | 0 | 16 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 33 | 0 | 0 | 33 |
nonstructural protein 1 | 9 | 0 | 0 | 9 |
GTP-binding nuclear protein Ran isoform 1 | 5 | 0 | 0 | 5 |
muscleblind-like protein 1 isoform 1 | 12 | 0 | 0 | 12 |
neuropeptide S receptor isoform A | 11 | 0 | 0 | 11 |
Beta-glucuronidase | 0 | 1 | 0 | 1 |
Cholinesterase | 0 | 8 | 0 | 8 |
Aromatase | 0 | 9 | 0 | 12 |
Gastrin/cholecystokinin type B receptor | 0 | 0 | 0 | 1 |
Testosterone 17-beta-dehydrogenase 3 | 0 | 3 | 0 | 3 |
Alpha-synuclein | 3 | 5 | 1 | 9 |
TAR DNA-binding protein 43 | 13 | 1 | 0 | 14 |
Chain A, retinol dehydratase | 0 | 1 | 0 | 1 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 4 | 0 | 4 |
G-protein coupled bile acid receptor 1 | 0 | 0 | 5 | 5 |
DNA polymerase kappa isoform 1 | 22 | 0 | 0 | 22 |
Atrial natriuretic peptide receptor 3 | 0 | 1 | 0 | 1 |
Type-1A angiotensin II receptor | 0 | 3 | 1 | 4 |
Type-1 angiotensin II receptor | 0 | 0 | 1 | 1 |
Type-1B angiotensin II receptor | 0 | 4 | 0 | 4 |
Type-1 angiotensin II receptor | 0 | 3 | 2 | 6 |
Type-2 angiotensin II receptor | 0 | 3 | 0 | 3 |
Type-2 angiotensin II receptor | 0 | 3 | 0 | 3 |
cytochrome P450 2D6 | 17 | 0 | 0 | 17 |
thyroid stimulating hormone receptor | 24 | 0 | 0 | 24 |
cytochrome P450 2C9 precursor | 13 | 0 | 0 | 13 |
Integrin beta-3 | 12 | 1 | 1 | 14 |
Integrin alpha-IIb | 12 | 1 | 1 | 14 |
5-hydroxytryptamine receptor 1A | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 2C | 0 | 3 | 0 | 4 |
Tryptophan 5-hydroxylase 1 | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 5 | 2 | 10 |
5-hydroxytryptamine receptor 2A | 0 | 3 | 0 | 3 |
D | 0 | 4 | 0 | 4 |
D(3) dopamine receptor | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 1A | 0 | 9 | 0 | 9 |
Alpha-2B adrenergic receptor | 0 | 5 | 0 | 5 |
D(2) dopamine receptor | 0 | 3 | 0 | 3 |
D(1A) dopamine receptor | 0 | 5 | 2 | 10 |
D(4) dopamine receptor | 0 | 6 | 1 | 9 |
D(1B) dopamine receptor | 0 | 3 | 0 | 5 |
Alpha-2C adrenergic receptor | 0 | 5 | 0 | 5 |
Alpha-2A adrenergic receptor | 0 | 5 | 0 | 5 |
Alpha-1D adrenergic receptor | 0 | 8 | 0 | 8 |
D(1B) dopamine receptor | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 2A | 0 | 5 | 0 | 5 |
5-hydroxytryptamine receptor 1B | 0 | 5 | 0 | 5 |
5-hydroxytryptamine receptor 1D | 0 | 1 | 0 | 1 |
D(4) dopamine receptor | 0 | 3 | 1 | 4 |
5-hydroxytryptamine receptor 1F | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 6 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 5B | 0 | 1 | 0 | 1 |
D(3) dopamine receptor | 0 | 7 | 1 | 10 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
Spike glycoprotein | 18 | 1 | 3 | 22 |
D(2) dopamine receptor | 0 | 5 | 2 | 8 |
E3 ubiquitin-protein ligase Mdm2 | 0 | 2 | 0 | 2 |
D | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 1 | 0 | 1 |
D | 0 | 3 | 0 | 3 |
ATPase family AAA domain-containing protein 5 | 19 | 0 | 0 | 19 |
Sigma non-opioid intracellular receptor 1 | 0 | 7 | 2 | 9 |
5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
Chain A, ADIPOCYTE LIPID-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain A, SERUM ALBUMIN | 0 | 0 | 2 | 2 |
Chain A, SERUM ALBUMIN | 0 | 0 | 2 | 2 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 8 | 0 | 0 | 8 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 9 | 0 | 0 | 9 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 6 | 0 | 0 | 6 |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 2 | 1 | 0 | 3 |
Fatty-acid amide hydrolase 1 | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 4 |
Trypsin | 0 | 2 | 0 | 2 |
Coagulation factor VII | 0 | 2 | 0 | 2 |
Tissue factor | 0 | 4 | 0 | 4 |
Fatty acid-binding protein, adipocyte | 0 | 3 | 1 | 4 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 2 | 2 |
Calmodulin | 0 | 2 | 2 | 5 |
Disintegrin and metalloproteinase domain-containing protein 17 | 7 | 1 | 0 | 8 |
Prostaglandin G/H synthase 2 | 0 | 4 | 0 | 5 |
Fatty acid-binding protein 5 | 0 | 2 | 0 | 2 |
Fatty acid-binding protein 5 | 0 | 0 | 1 | 1 |
Lanosterol 14-alpha demethylase | 0 | 2 | 0 | 2 |
Solute carrier organic anion transporter family member 1B3 | 0 | 10 | 0 | 14 |
Cytosolic phospholipase A2 gamma | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily V member 2 | 0 | 2 | 0 | 2 |
Solute carrier organic anion transporter family member 1B1 | 0 | 12 | 0 | 16 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 3 | 3 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 3 | 3 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 3 | 3 |
Nitric oxide synthase, endothelial | 0 | 2 | 0 | 4 |
Nitric oxide synthase, brain | 0 | 3 | 0 | 4 |
Nitric oxide synthase, brain | 0 | 3 | 0 | 4 |
Nitric oxide synthase, inducible | 0 | 3 | 0 | 4 |
Nitric oxide synthase, inducible | 0 | 3 | 1 | 6 |
Cationic amino acid transporter 3 | 0 | 1 | 0 | 1 |
Glycogen phosphorylase, muscle form | 0 | 3 | 0 | 3 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 6 | 0 | 6 |
Chain A, Hyaluronidase, phage associated | 0 | 1 | 0 | 1 |
Pancreatic alpha-amylase | 0 | 2 | 0 | 2 |
Albumin | 0 | 1 | 0 | 1 |
Urease | 0 | 1 | 0 | 1 |
Prolyl 4-hydroxylase subunit alpha-1 | 0 | 0 | 0 | 1 |
Alpha-2B adrenergic receptor | 0 | 2 | 1 | 3 |
Hyaluronate lyase | 0 | 1 | 0 | 1 |
Prolyl hydroxylase EGLN2 | 0 | 0 | 1 | 2 |
Egl nine homolog 1 | 0 | 0 | 1 | 2 |
Prolyl hydroxylase EGLN3 | 0 | 0 | 1 | 2 |
Hypoxia-inducible factor 1-alpha inhibitor | 0 | 1 | 0 | 2 |
Solute carrier family 23 member 1 | 0 | 1 | 0 | 1 |
Metabotropic glutamate receptor 6 | 0 | 1 | 2 | 4 |
Excitatory amino acid transporter 4 | 0 | 2 | 0 | 2 |
Glutamate transporter homolog | 0 | 0 | 1 | 1 |
N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase | 0 | 1 | 0 | 1 |
Excitatory amino acid transporter 1 | 0 | 3 | 0 | 4 |
Excitatory amino acid transporter 2 | 0 | 3 | 0 | 4 |
Excitatory amino acid transporter 3 | 0 | 3 | 0 | 4 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 7 | 2 | 13 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 7 | 2 | 13 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 7 | 2 | 14 |
Metabotropic glutamate receptor 1 | 0 | 1 | 2 | 4 |
Metabotropic glutamate receptor 2 | 0 | 1 | 2 | 4 |
Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 7 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 7 | 2 | 13 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 7 | 2 | 13 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 7 | 2 | 13 |
Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
GTP-binding protein (rab7) | 0 | 0 | 2 | 2 |
ras protein, partial | 0 | 0 | 2 | 2 |
Rac1 protein | 0 | 0 | 2 | 2 |
cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 2 | 2 |
Prostaglandin-H2 D-isomerase | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Epidermal growth factor receptor | 0 | 5 | 0 | 5 |
Fatty acid-binding protein, liver | 0 | 3 | 0 | 3 |
Myeloperoxidase | 0 | 4 | 0 | 4 |
Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 1 | 3 | 0 | 7 |
Adenosine receptor A2a | 0 | 3 | 0 | 6 |
Urotensin-2 receptor | 0 | 1 | 0 | 1 |
4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
Ras-related protein Rab-2A | 0 | 0 | 2 | 2 |
Rho-associated protein kinase 2 | 0 | 1 | 0 | 1 |
Nicotinate phosphoribosyltransferase | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 20 | 0 | 6 | 0 | 6 |
Solute carrier family 22 member 6 | 0 | 6 | 0 | 7 |
Sigma non-opioid intracellular receptor 1 | 0 | 3 | 2 | 5 |
Solute carrier organic anion transporter family member 2B1 | 0 | 0 | 0 | 2 |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 2 | 0 | 2 |
ATP-dependent translocase ABCB1 | 0 | 9 | 3 | 21 |
Insulin receptor | 0 | 1 | 0 | 1 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 1 | 0 | 1 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 9 | 2 | 12 |
glp-1 receptor, partial | 16 | 0 | 0 | 16 |
Fumarate hydratase | 11 | 0 | 0 | 11 |
PPM1D protein | 9 | 0 | 0 | 9 |
polyprotein | 11 | 0 | 0 | 11 |
hemoglobin subunit beta | 3 | 0 | 0 | 3 |
Interferon beta | 25 | 0 | 0 | 25 |
DNA (cytosine-5)-methyltransferase 1 | 0 | 2 | 0 | 2 |
Adenosine receptor A1 | 0 | 4 | 0 | 4 |
Multidrug and toxin extrusion protein 1 | 0 | 4 | 0 | 4 |
Histone-lysine N-methyltransferase EHMT2 | 0 | 1 | 0 | 1 |
G | 17 | 0 | 0 | 17 |
P53 | 2 | 0 | 0 | 2 |
HLA class I histocompatibility antigen, B alpha chain | 17 | 0 | 0 | 17 |
Inositol hexakisphosphate kinase 1 | 17 | 0 | 0 | 17 |
Protein-arginine deiminase type-4 | 0 | 2 | 0 | 2 |
cytochrome P450 2C9, partial | 17 | 0 | 0 | 17 |
Chain A, Integrase | 0 | 1 | 0 | 1 |
Chain A, Integrase | 0 | 1 | 0 | 1 |
Chain A, T4 LYSOZYME | 0 | 0 | 1 | 1 |
Chain A, GCN4P1 | 0 | 0 | 1 | 1 |
Chain B, GCN4P1 | 0 | 0 | 1 | 1 |
Chain C, GCN4P1 | 0 | 0 | 1 | 1 |
Chain A, T4 LYSOZYME | 0 | 0 | 1 | 1 |
Chain A, T4 LYSOZYME | 0 | 0 | 1 | 1 |
Chain A, Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
Chain A, 3C-like proteinase | 0 | 1 | 0 | 1 |
Endolysin | 0 | 0 | 1 | 1 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 8 | 0 | 0 | 8 |
DNA dC->dU-editing enzyme APOBEC-3F isoform a | 2 | 0 | 0 | 2 |
Receptor tyrosine-protein kinase erbB-2 | 0 | 2 | 0 | 2 |
Aryl hydrocarbon receptor | 0 | 0 | 1 | 1 |
Chain A, Betaine ABC transporter permease and substrate binding protein | 0 | 0 | 1 | 1 |
Chain A, Osmoprotection protein (ProX) | 0 | 0 | 1 | 1 |
Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 1 | 1 |
Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 1 | 1 |
Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 1 | 1 |
Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 1 | 1 |
Solute carrier family 12 member 2 | 0 | 1 | 0 | 1 |
Chain A, Vitamin D Nuclear Receptor | 0 | 0 | 1 | 1 |
Vitamin D3 receptor | 0 | 0 | 1 | 1 |
Vitamin D-binding protein | 0 | 0 | 1 | 1 |
Androgen receptor | 0 | 9 | 3 | 16 |
Vitamin D3 receptor | 0 | 2 | 3 | 9 |
Vitamin D3 receptor | 0 | 1 | 1 | 3 |
Retinoic acid receptor RXR-alpha | 0 | 2 | 5 | 7 |
Cytochrome P450 2C19 | 0 | 5 | 1 | 6 |
Kappa-type opioid receptor | 0 | 7 | 2 | 9 |
Vitamin D3 receptor | 0 | 0 | 2 | 2 |
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial | 0 | 0 | 1 | 1 |
Vitamin D3 receptor | 0 | 1 | 1 | 2 |
Transporter | 0 | 1 | 0 | 1 |
Vitamin D3 receptor A | 0 | 0 | 2 | 2 |
Chain A, angiotensin converting enzyme | 0 | 1 | 0 | 1 |
Chain A, angiotensin converting enzyme | 0 | 1 | 0 | 1 |
Metallo-beta-lactamase type 2 | 0 | 1 | 1 | 2 |
transient receptor potential cation channel subfamily V member 1 | 1 | 0 | 0 | 1 |
Renin | 0 | 1 | 0 | 1 |
Neprilysin | 0 | 1 | 0 | 1 |
Neprilysin | 0 | 1 | 0 | 1 |
Leukotriene A-4 hydrolase | 0 | 3 | 1 | 4 |
EEF1AKMT4-ECE2 readthrough transcript protein | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 5 | 1 | 6 |
Angiotensin-converting enzyme | 0 | 4 | 0 | 5 |
Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Thymidine phosphorylase | 0 | 0 | 1 | 2 |
Endothelin-converting enzyme 1 | 0 | 1 | 0 | 1 |
Succinyl-diaminopimelate desuccinylase | 0 | 3 | 0 | 3 |
Angiotensin-converting enzyme | 0 | 2 | 1 | 3 |
Beta-lactamase TEM | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 5 | 2 | 8 |
Beta-lactamase | 0 | 3 | 0 | 4 |
Beta-lactamase | 0 | 3 | 0 | 3 |
Angiotensin-converting enzyme 2 | 0 | 2 | 3 | 5 |
Beta-lactamase class B VIM-2 | 0 | 1 | 1 | 2 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
UDP-glucuronosyltransferase 1A4 | 0 | 1 | 0 | 3 |
Secreted chorismate mutase | 0 | 1 | 0 | 1 |
DNA polymerase eta isoform 1 | 5 | 0 | 0 | 5 |
Arginase | 0 | 3 | 0 | 3 |
Pancreatic triacylglycerol lipase | 0 | 4 | 0 | 4 |
Sucrase-isomaltase, intestinal | 0 | 1 | 0 | 1 |
Melatonin receptor type 1A | 0 | 2 | 2 | 4 |
Melatonin receptor type 1B | 0 | 2 | 2 | 4 |
Death-associated protein kinase 1 | 0 | 4 | 0 | 4 |
Carbonic anhydrase 3 | 0 | 3 | 0 | 3 |
interferon gamma precursor | 0 | 0 | 0 | 2 |
GALC protein | 5 | 0 | 0 | 5 |
FAD-linked sulfhydryl oxidase ALR | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 5 | 0 | 9 |
Proteasome subunit beta type-11 | 0 | 0 | 0 | 1 |
NADPH oxidase 1 | 0 | 1 | 0 | 1 |
Snq2p | 0 | 0 | 0 | 1 |
Adenylate cyclase type 1 | 0 | 2 | 0 | 2 |
Spike glycoprotein | 0 | 1 | 3 | 4 |
Replicase polyprotein 1ab | 0 | 4 | 3 | 7 |
histone deacetylase 9 isoform 3 | 4 | 0 | 0 | 4 |
atrial natriuretic peptide receptor 2 precursor | 4 | 0 | 0 | 4 |
Proteasome subunit alpha type-7 | 0 | 0 | 0 | 1 |
Transmembrane protease serine 2 | 0 | 1 | 3 | 4 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 3 | 1 | 4 |
Transient receptor potential cation channel subfamily V member 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 3 | 1 | 4 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 3 | 0 | 3 |
Potassium channel subfamily K member 2 | 0 | 1 | 1 | 2 |
Albumin | 0 | 2 | 3 | 6 |
Albumin | 0 | 0 | 2 | 2 |
Major prion protein | 0 | 0 | 1 | 1 |
Major prion protein | 0 | 0 | 1 | 1 |
Procathepsin L | 0 | 2 | 3 | 5 |
Muscarinic acetylcholine receptor M2 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M1 | 0 | 4 | 2 | 6 |
Muscarinic acetylcholine receptor M3 | 0 | 4 | 2 | 6 |
Muscarinic acetylcholine receptor M4 | 0 | 4 | 2 | 6 |
Muscarinic acetylcholine receptor M5 | 0 | 4 | 2 | 6 |
Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 2 |
Replicase polyprotein 1a | 0 | 1 | 3 | 4 |
Replicase polyprotein 1ab | 0 | 1 | 3 | 4 |
Replicase polyprotein 1ab | 0 | 4 | 4 | 8 |
Cys-loop ligand-gated ion channel | 0 | 1 | 0 | 1 |
Calmodulin-1 | 0 | 4 | 1 | 5 |
Replicase polyprotein 1ab | 0 | 7 | 4 | 11 |
Muscarinic acetylcholine receptor M2 | 0 | 5 | 2 | 7 |
Muscarinic acetylcholine receptor M1 | 0 | 2 | 0 | 2 |
Sphingomyelin phosphodiesterase | 0 | 1 | 0 | 1 |
Alpha-2C adrenergic receptor | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 2 |
Proteasome subunit beta type-1 | 0 | 0 | 0 | 1 |
Adenylate cyclase type 3 | 0 | 2 | 0 | 2 |
Sodium-dependent dopamine transporter | 0 | 3 | 0 | 3 |
Histamine H2 receptor | 0 | 5 | 2 | 7 |
Alpha-1D adrenergic receptor | 0 | 2 | 1 | 3 |
Proteasome subunit alpha type-1 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-2 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-3 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-4 | 0 | 0 | 0 | 1 |
Adenylate cyclase type 2 | 0 | 2 | 0 | 2 |
Adenylate cyclase type 4 | 0 | 2 | 0 | 2 |
Proteasome subunit beta type-8 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-9 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-5 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-4 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-6 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-5 | 0 | 4 | 0 | 5 |
Trypanothione reductase | 0 | 2 | 0 | 2 |
Histamine H1 receptor | 0 | 2 | 3 | 5 |
Melanocortin receptor 4 | 0 | 2 | 0 | 2 |
Melanocortin receptor 5 | 0 | 2 | 0 | 2 |
Pleiotropic ABC efflux transporter of multiple drugs | 0 | 1 | 0 | 2 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
Histamine H1 receptor | 0 | 4 | 2 | 6 |
Sodium channel protein type 1 subunit alpha | 0 | 3 | 0 | 3 |
Sodium channel protein type 4 subunit alpha | 0 | 2 | 0 | 2 |
Adenylate cyclase type 8 | 0 | 2 | 0 | 2 |
Proteasome subunit beta type-10 | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 2B | 0 | 6 | 0 | 6 |
Melanocortin receptor 3 | 0 | 2 | 0 | 2 |
Proteasome subunit beta type-3 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-2 | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 6 | 0 | 4 | 0 | 4 |
Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
Proteasome subunit alpha type-6 | 0 | 0 | 1 | 2 |
Aldehyde oxidase 1 | 0 | 1 | 0 | 1 |
Sodium channel protein type 7 subunit alpha | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 3 | 0 | 3 |
Adenylate cyclase type 6 | 0 | 2 | 0 | 2 |
Adenylate cyclase type 5 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 4 | 1 | 5 |
Aldehyde oxidase | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 4 | 1 | 5 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 4 | 1 | 5 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 3 | 0 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 4 | 0 | 4 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 3 | 1 | 4 |
Sodium channel protein type 9 subunit alpha | 0 | 2 | 0 | 2 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 2 | 0 | 2 |
Adenylyl cyclase 7 | 0 | 2 | 0 | 2 |
Proteasome subunit alpha-type 8 | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 3 | 1 | 4 |
Sodium channel protein type 2 subunit alpha | 0 | 3 | 0 | 3 |
Proteasome subunit beta type-7 | 0 | 0 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 3 | 0 | 3 |
Sodium channel protein type 11 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 8 subunit alpha | 0 | 2 | 0 | 2 |
Histamine H3 receptor | 0 | 3 | 2 | 5 |
Sodium channel protein type 10 subunit alpha | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-1 | 0 | 0 | 2 | 2 |
Chain A, Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
Chain A, Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
Chain A, Transthyretin | 0 | 0 | 1 | 1 |
Chain A, Transthyretin | 0 | 0 | 1 | 1 |
Chain A, Transthyretin | 0 | 0 | 1 | 1 |
Chain A, Transthyretin | 0 | 0 | 1 | 1 |
Chain B, Transthyretin | 0 | 0 | 1 | 1 |
Chain A, Transthyretin | 0 | 0 | 1 | 1 |
Chain B, Transthyretin | 0 | 0 | 1 | 1 |
Nrf2 | 3 | 0 | 0 | 3 |
BRCA1 | 1 | 0 | 0 | 1 |
Neuraminidase | 0 | 3 | 0 | 3 |
nuclear receptor subfamily 0 group B member 1 | 0 | 1 | 0 | 1 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 11 | 0 | 0 | 11 |
glycogen synthase kinase-3 beta isoform 1 | 0 | 0 | 1 | 1 |
steroidogenic factor 1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 3 | 0 | 3 |
G2/mitotic-specific cyclin-B2 | 0 | 2 | 0 | 2 |
Triosephosphate isomerase | 0 | 1 | 0 | 1 |
Glucocorticoid receptor | 0 | 5 | 2 | 14 |
Cyclin-dependent kinase 1 | 0 | 2 | 0 | 2 |
Serine/threonine-protein kinase pim-1 | 0 | 3 | 1 | 4 |
Cytochrome P450 2A6 | 0 | 1 | 0 | 2 |
G2/mitotic-specific cyclin-B1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 3 | 0 | 3 |
Urease subunit alpha | 0 | 4 | 0 | 4 |
G2/mitotic-specific cyclin-B | 0 | 2 | 0 | 2 |
Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
Carbonyl reductase [NADPH] 1 | 0 | 2 | 0 | 2 |
Glycogen synthase kinase-3 beta | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 3 | 0 | 3 |
Casein kinase II subunit alpha' | 0 | 4 | 0 | 4 |
Cytochrome P450 2B6 | 0 | 2 | 0 | 2 |
Amine oxidase [flavin-containing] B | 0 | 6 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 3 | 0 | 3 |
Receptor-type tyrosine-protein kinase FLT3 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 3 | 0 | 3 |
Glycogen synthase kinase-3 alpha | 0 | 2 | 0 | 2 |
Glycogen synthase kinase-3 beta | 0 | 3 | 0 | 3 |
Mitogen-activated protein kinase 10 | 0 | 3 | 0 | 3 |
Casein kinase II subunit beta | 0 | 4 | 0 | 4 |
Casein kinase II subunit alpha | 0 | 4 | 0 | 4 |
Urease subunit beta | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit epsilon | 0 | 3 | 0 | 3 |
Xanthine dehydrogenase/oxidase | 0 | 5 | 0 | 6 |
Cyclin-dependent kinase 6 | 0 | 2 | 0 | 2 |
Cyclin-dependent-like kinase 5 | 0 | 2 | 0 | 2 |
Cyclin homolog | 0 | 2 | 0 | 2 |
Lactoylglutathione lyase | 0 | 6 | 0 | 6 |
Cyclin-dependent kinase 5 activator 1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 3 | 0 | 3 |
Mitogen-activated protein kinase 14 | 0 | 4 | 0 | 4 |
Cytochrome P450 1B1 | 0 | 5 | 1 | 6 |
Substance-K receptor | 0 | 2 | 0 | 2 |
Integrase | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 3 | 0 | 3 |
Casein kinase II subunit alpha 3 | 0 | 4 | 0 | 4 |
G2/mitotic-specific cyclin-B3 | 0 | 2 | 0 | 2 |
3-oxoacyl-acyl-carrier protein reductase | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 3 | 0 | 3 |
Cyclin-dependent kinase 1 | 0 | 2 | 0 | 2 |
Dipeptidyl peptidase 3 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 3 | 0 | 3 |
Sialidase-2 | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
Chain A, N5-carboxyaminoimidazole ribonucleotide mutase | 0 | 0 | 1 | 1 |
Chain B, N5-carboxyaminoimidazole ribonucleotide mutase | 0 | 0 | 1 | 1 |
Chain A, N5-carboxyaminoimidazole ribonucleotide mutase | 0 | 0 | 1 | 1 |
Chain B, N5-carboxyaminoimidazole ribonucleotide mutase | 0 | 0 | 1 | 1 |
hepatocyte nuclear factor 4-alpha isoform 2 | 0 | 1 | 0 | 1 |
perilipin-5 | 0 | 2 | 0 | 2 |
perilipin-1 | 0 | 2 | 0 | 2 |
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 2 | 0 | 2 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Proto-oncogene tyrosine-protein kinase Src | 0 | 2 | 0 | 2 |
3-dehydroquinate dehydratase | 0 | 0 | 1 | 1 |
ATP-citrate synthase | 0 | 1 | 0 | 2 |
Ribonuclease T | 0 | 0 | 0 | 1 |
Cell death-related nuclease 4 | 0 | 0 | 0 | 1 |
3-dehydroquinate dehydratase | 0 | 0 | 1 | 1 |
Prolyl 4-hydroxylase | 0 | 3 | 0 | 3 |
Alpha-ketoglutarate-dependent dioxygenase FTO | 0 | 3 | 0 | 3 |
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 | 0 | 2 | 0 | 2 |
General amino-acid permease GAP1 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 2 | 0 | 5 |
Solute carrier family 22 member 3 | 0 | 4 | 0 | 5 |
Solute carrier family 22 member 3 | 0 | 1 | 0 | 2 |
C-8 sterol isomerase | 0 | 1 | 0 | 1 |
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 1 | 0 | 1 |
nuclear receptor subfamily 1, group I, member 2 | 2 | 0 | 0 | 2 |
glycogen synthase kinase-3 alpha | 0 | 0 | 0 | 1 |
Exportin-1 | 0 | 1 | 0 | 1 |
NAD-dependent histone deacetylase SIR2 | 0 | 1 | 0 | 3 |
UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 2 |
Amine oxidase [flavin-containing] B | 0 | 2 | 0 | 2 |
Cytochrome P450 2A5 | 0 | 0 | 0 | 1 |
Amine oxidase [flavin-containing] A | 0 | 2 | 1 | 3 |
UDP-glucuronosyltransferase 2B10 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 1 | 0 | 3 |
Sodium- and chloride-dependent creatine transporter 1 | 0 | 1 | 0 | 1 |
Chain A, Breast cancer type 1 susceptibility protein | 1 | 0 | 0 | 1 |
PINK1 | 2 | 0 | 0 | 2 |
toll-like receptor 9 | 0 | 1 | 0 | 1 |
TPA: protein transporter TIM10 | 0 | 1 | 0 | 1 |
thyrotropin-releasing hormone receptor | 7 | 0 | 0 | 7 |
transcriptional regulator ERG isoform 3 | 3 | 0 | 0 | 3 |
pyruvate kinase PKM isoform a | 2 | 0 | 0 | 2 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 8 | 0 | 0 | 8 |
tumor susceptibility gene 101 protein | 1 | 0 | 0 | 1 |
hypothetical protein SA1422 | 0 | 1 | 0 | 1 |
Prostaglandin E synthase | 0 | 2 | 0 | 2 |
Lysine-specific histone demethylase 1A | 0 | 2 | 0 | 2 |
D-amino-acid oxidase | 0 | 1 | 0 | 1 |
Phospholipase A2 | 0 | 3 | 0 | 3 |
Amyloid-beta precursor protein | 0 | 9 | 0 | 10 |
Neuronal proto-oncogene tyrosine-protein kinase Src | 0 | 1 | 0 | 1 |
Heme oxygenase 1 | 0 | 2 | 0 | 2 |
Glutathione S-transferase P | 0 | 2 | 0 | 2 |
Microtubule-associated protein tau | 0 | 2 | 0 | 3 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | 0 | 1 | 0 | 1 |
Aminopeptidase N | 0 | 1 | 0 | 1 |
Aminopeptidase N | 0 | 1 | 0 | 1 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 3 | 0 | 3 |
Heme oxygenase 2 | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 3 | 0 | 3 |
17-beta-hydroxysteroid dehydrogenase type 2 | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 3 | 0 | 3 |
Histone acetyltransferase p300 | 0 | 2 | 0 | 2 |
Serine/threonine-protein kinase PAK 1 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 0 | 1 | 1 |
Sodium/bile acid cotransporter | 0 | 1 | 1 | 2 |
Nuclear factor erythroid 2-related factor 2 | 0 | 0 | 2 | 3 |
Thioredoxin reductase 1, cytoplasmic | 0 | 1 | 0 | 1 |
Thioredoxin reductase 3 | 0 | 1 | 0 | 1 |
Sortase A | 0 | 2 | 0 | 2 |
CREB-binding protein | 1 | 2 | 0 | 3 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 | 0 | 2 | 0 | 2 |
Cysteine protease | 0 | 1 | 0 | 1 |
NACHT, LRR and PYD domains-containing protein 3 | 0 | 2 | 0 | 2 |
Thioredoxin reductase 2, mitochondrial | 0 | 1 | 0 | 1 |
CDGSH iron-sulfur domain-containing protein 1 | 0 | 6 | 0 | 6 |
Lymphocyte antigen 96 | 0 | 0 | 1 | 1 |
Beta lactamase (plasmid) | 0 | 1 | 0 | 1 |
Phosphodiesterase | 0 | 1 | 0 | 1 |
Multidrug resistance-associated protein 5 | 0 | 0 | 0 | 1 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 4 | 0 | 4 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 4 | 0 | 4 |
RPL19A | 0 | 0 | 1 | 1 |
NPC intracellular cholesterol transporter 1 precursor | 3 | 0 | 0 | 3 |
heat shock protein HSP 90-alpha isoform 2 | 0 | 0 | 0 | 1 |
transactivating tegument protein VP16 [Human herpesvirus 1] | 0 | 2 | 0 | 2 |
COUP transcription factor 2 isoform a | 0 | 1 | 0 | 1 |
Glucose transporter | 0 | 1 | 0 | 1 |
Hexose transporter 1 | 0 | 1 | 0 | 1 |
Solute carrier family 2, facilitated glucose transporter member 1 | 0 | 2 | 0 | 2 |
Eukaryotic initiation factor 4A-I | 0 | 1 | 0 | 1 |
Peptidyl-prolyl cis-trans isomerase FKBP1A | 0 | 2 | 0 | 2 |
Peptidyl-prolyl cis-trans isomerase FKBP3 | 0 | 1 | 0 | 1 |
Peptidyl-prolyl cis-trans isomerase FKBP4 | 0 | 1 | 0 | 1 |
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 0 | 4 | 1 | 5 |
Hypoxia-inducible factor 1-alpha | 0 | 1 | 1 | 2 |
Endothelial PAS domain-containing protein 1 | 0 | 1 | 0 | 1 |
Peptidyl-prolyl cis-trans isomerase FKBP14 | 0 | 1 | 0 | 1 |
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4 | 0 | 1 | 0 | 1 |
heat shock protein 90, putative | 0 | 0 | 0 | 1 |
Rap guanine nucleotide exchange factor 3 | 8 | 0 | 0 | 8 |
Alpha-tocopherol transfer protein | 0 | 0 | 1 | 1 |
RAD51 | 0 | 1 | 0 | 1 |
Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 | 0 | 1 | 0 | 1 |
Growth factor receptor-bound protein 2 | 0 | 1 | 0 | 1 |
Pantothenate synthetase | 0 | 1 | 0 | 1 |
Discoidin domain-containing receptor 2 | 0 | 1 | 0 | 1 |
Growth factor receptor-bound protein 2 | 0 | 1 | 0 | 1 |
Reverse transcriptase/RNaseH | 0 | 2 | 0 | 2 |
Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase | 0 | 0 | 1 | 1 |
Vasopressin V2 receptor | 0 | 2 | 1 | 3 |
Oxytocin receptor | 0 | 0 | 1 | 1 |
Vasopressin V1a receptor | 0 | 1 | 1 | 2 |
Vasopressin V1b receptor | 0 | 1 | 1 | 2 |
Translocator protein | 0 | 1 | 0 | 1 |
Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
Lysine-specific demethylase 6B | 0 | 1 | 0 | 1 |
Lysine-specific demethylase 4A | 0 | 3 | 1 | 4 |
Lysine-specific demethylase 5A | 0 | 1 | 0 | 1 |
Flavin reductase (NADPH) | 0 | 0 | 2 | 2 |
Potassium voltage-gated channel subfamily D member 3 | 0 | 1 | 0 | 1 |
Lysine-specific demethylase 6A | 0 | 1 | 0 | 1 |
Lysine-specific demethylase 5C | 0 | 1 | 0 | 1 |
Lysine-specific demethylase 2B | 0 | 1 | 0 | 1 |
Deoxyhypusine hydroxylase | 0 | 2 | 0 | 2 |
Lysine-specific demethylase 2A | 0 | 1 | 0 | 1 |
Methylcytosine dioxygenase TET2 | 0 | 1 | 0 | 1 |
Thymidine kinase, cytosolic | 0 | 3 | 0 | 6 |
Deoxycytidine kinase | 0 | 0 | 0 | 1 |
AAA family ATPase | 0 | 0 | 0 | 1 |
Sterol O-acyltransferase 1 | 0 | 2 | 0 | 2 |
Hsf1 protein | 0 | 0 | 1 | 1 |
Chain A, Sex Hormone-Binding Globulin | 0 | 0 | 1 | 1 |
Progesterone receptor | 0 | 1 | 0 | 1 |
Progesterone receptor | 0 | 5 | 2 | 8 |
Glucocorticoid receptor | 0 | 2 | 1 | 3 |
Sex hormone-binding globulin | 0 | 1 | 0 | 1 |
Androgen receptor | 0 | 1 | 2 | 3 |
Cannabinoid receptor 2 | 0 | 1 | 1 | 2 |
Muscarinic acetylcholine receptor | 0 | 1 | 0 | 1 |
Neuropeptide FF receptor 2 | 0 | 0 | 0 | 2 |
ALK tyrosine kinase receptor | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
Potassium voltage-gated channel subfamily A member 1 | 0 | 2 | 0 | 2 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
Vpr | 2 | 0 | 0 | 2 |
Glutathione S-transferase omega-1 | 0 | 1 | 0 | 1 |
prostaglandin E2 receptor EP2 subtype | 1 | 0 | 0 | 2 |
Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 3 |
Prostaglandin E2 receptor EP3 subtype | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP1 subtype | 0 | 2 | 1 | 3 |
Prostaglandin E2 receptor EP1 subtype | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP4 subtype | 0 | 2 | 1 | 3 |
Prostaglandin F2-alpha receptor | 0 | 0 | 1 | 1 |
Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 1 | 2 |
Prostaglandin E2 receptor EP3 subtype | 0 | 2 | 1 | 3 |
Prostaglandin E2 receptor EP2 subtype | 0 | 2 | 1 | 3 |
Prostacyclin receptor | 0 | 2 | 1 | 3 |
Solute carrier family 22 member 6 | 0 | 4 | 0 | 8 |
Solute carrier family 22 member 7 | 0 | 2 | 0 | 4 |
Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 1 | 2 |
Solute carrier family 22 member 8 | 0 | 4 | 0 | 7 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 2 |
Solute carrier family 22 member 11 | 0 | 0 | 0 | 2 |
Solute carrier organic anion transporter family member 1B2 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
Gasdermin-D | 0 | 1 | 0 | 1 |
Gasdermin-D | 0 | 1 | 0 | 1 |
Eyes absent homolog 2 | 0 | 1 | 0 | 1 |
Metallo-beta-lactamase VIM-13 | 0 | 1 | 0 | 1 |
Beta-lactamase VIM-1 | 0 | 1 | 0 | 1 |
Endothelin-1 receptor | 0 | 1 | 0 | 1 |
Chain A, Troponin C, slow skeletal and cardiac muscles | 0 | 0 | 1 | 1 |
Chain A, Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 0 | 0 | 1 | 1 |
Chain A, POLYMERASE PA | 0 | 1 | 0 | 1 |
Chain A, Polymerase Pa | 0 | 1 | 0 | 1 |
Chain A, Polymerase Pa | 0 | 1 | 0 | 1 |
Chain A, Polymerase Pa | 0 | 1 | 0 | 1 |
Chain A, Polymerase Pa | 0 | 1 | 0 | 1 |
Genome polyprotein | 0 | 2 | 1 | 3 |
galactokinase | 3 | 0 | 0 | 3 |
Telomerase reverse transcriptase | 0 | 1 | 0 | 1 |
Polycomb protein EED | 0 | 0 | 1 | 1 |
NAD kinase | 0 | 2 | 1 | 3 |
Dihydrofolate reductase | 0 | 4 | 0 | 6 |
Transthyretin | 0 | 1 | 1 | 4 |
Polymerase acidic protein | 0 | 1 | 1 | 2 |
Plasminogen activator inhibitor 1 | 0 | 1 | 0 | 1 |
Neutrophil elastase | 0 | 3 | 0 | 3 |
72 kDa type IV collagenase | 0 | 2 | 0 | 2 |
Hepatocyte growth factor receptor | 0 | 3 | 0 | 3 |
Matrilysin | 0 | 1 | 0 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | 0 | 2 | 0 | 2 |
Alpha-amylase 1A | 0 | 2 | 0 | 2 |
Apoptosis regulator Bcl-2 | 0 | 4 | 1 | 5 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
Fatty acid synthase | 0 | 1 | 0 | 1 |
CPG DNA methylase | 0 | 1 | 0 | 1 |
Lethal factor | 0 | 1 | 0 | 1 |
Phosphoglycerate mutase 1 | 0 | 1 | 0 | 1 |
Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
Dipeptidyl peptidase 4 | 0 | 2 | 0 | 2 |
Cannabinoid receptor 2 | 0 | 1 | 0 | 1 |
Signal transducer and activator of transcription 1-alpha/beta | 0 | 0 | 1 | 1 |
DNA repair protein RAD52 homolog | 0 | 2 | 0 | 2 |
Fatty acid synthase | 0 | 2 | 0 | 2 |
Matrix metalloproteinase-14 | 0 | 1 | 0 | 1 |
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6 | 0 | 1 | 0 | 1 |
Squalene monooxygenase | 0 | 1 | 0 | 1 |
6-phosphogluconate dehydrogenase, decarboxylating | 0 | 2 | 0 | 2 |
BH3-interacting domain death agonist | 0 | 2 | 0 | 2 |
Lactoperoxidase | 0 | 1 | 0 | 2 |
Bcl-2-like protein 1 | 0 | 3 | 1 | 4 |
Alpha-(1,3)-fucosyltransferase 7 | 0 | 1 | 0 | 1 |
CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 | 0 | 1 | 0 | 1 |
Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 0 | 1 | 0 | 1 |
Bcl-2-related protein A1 | 0 | 1 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 2 | 1 | 3 |
Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 0 | 1 | 0 | 1 |
3-oxoacyl-[acyl-carrier-protein] reductase | 0 | 1 | 0 | 1 |
MAP kinase-activated protein kinase 5 | 0 | 1 | 0 | 1 |
Histone acetyltransferase KAT2B | 0 | 1 | 0 | 1 |
Bcl-2-like protein 2 | 0 | 2 | 0 | 2 |
Bcl2-associated agonist of cell death | 0 | 2 | 0 | 2 |
Histone acetyltransferase KAT5 | 0 | 1 | 0 | 1 |
Enoyl-acyl-carrier protein reductase | 0 | 5 | 0 | 5 |
Beta-hydroxyacyl-ACP dehydratase precursor (Fatty acid synthesis protein) | 0 | 3 | 0 | 3 |
Bcl-2-like protein 10 | 0 | 1 | 0 | 1 |
chaperonin-containing TCP-1 beta subunit homolog | 2 | 0 | 0 | 2 |
eyes absent homolog 2 isoform a | 4 | 0 | 0 | 4 |
relaxin receptor 1 isoform 1 | 1 | 0 | 0 | 1 |
large T antigen | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel subunit alpha-2/delta-1 | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 3 | 2 | 5 |
PAX8 | 0 | 0 | 0 | 1 |
delta-type opioid receptor | 0 | 0 | 1 | 1 |
mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 5A | 0 | 0 | 1 | 1 |
Sodium/hydrogen exchanger 1 | 0 | 2 | 0 | 2 |
Sodium/hydrogen exchanger 2 | 0 | 1 | 0 | 1 |
Chain H, IGG1-KAPPA DB3 FAB (HEAVY CHAIN) | 0 | 1 | 0 | 1 |
Chain L, IGG1-KAPPA DB3 FAB (LIGHT CHAIN) | 0 | 1 | 0 | 1 |
Chain H, IGG1-KAPPA DB3 FAB (HEAVY CHAIN) | 0 | 1 | 0 | 1 |
Chain L, IGG1-KAPPA DB3 FAB (LIGHT CHAIN) | 0 | 1 | 0 | 1 |
Chain H, IGG1-KAPPA DB3 FAB (HEAVY CHAIN) | 0 | 1 | 0 | 1 |
Chain L, IGG1-KAPPA DB3 FAB (LIGHT CHAIN) | 0 | 1 | 0 | 1 |
ClpP | 3 | 0 | 0 | 3 |
Tyrosine-protein phosphatase non-receptor type 2 | 0 | 3 | 0 | 3 |
Tyrosine-protein phosphatase non-receptor type 1 | 0 | 9 | 0 | 11 |
Tyrosine-protein phosphatase non-receptor type 11 | 0 | 3 | 0 | 3 |
Nuclear factor NF-kappa-B p105 subunit | 0 | 1 | 1 | 2 |
Transcription factor p65 | 0 | 2 | 1 | 3 |
Asialoglycoprotein receptor 1 | 0 | 1 | 1 | 2 |
Chain A, GLUTAMATE RECEPTOR SUBUNIT 2 | 0 | 1 | 0 | 1 |
Chain A, Glutamate Receptor Subunit 2 | 0 | 1 | 0 | 1 |
Chain B, Glutamate Receptor Subunit 2 | 0 | 1 | 0 | 1 |
Chain A, Slr1257 protein | 0 | 0 | 1 | 1 |
Chain A, Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] | 0 | 1 | 0 | 1 |
beta-2 adrenergic receptor | 2 | 0 | 0 | 2 |
Metabotropic glutamate receptor 8 | 0 | 2 | 0 | 2 |
Glutathione reductase, mitochondrial | 0 | 3 | 0 | 3 |
Bifunctional aspartokinase/homoserine dehydrogenase 1 | 0 | 1 | 0 | 1 |
Glutamate receptor 1 | 1 | 3 | 1 | 5 |
Glutamate receptor 3 | 1 | 3 | 1 | 5 |
Glutamate receptor 4 | 1 | 3 | 1 | 5 |
Glutamate receptor ionotropic, kainate 1 | 0 | 2 | 1 | 3 |
Metabotropic glutamate receptor 1 | 0 | 2 | 1 | 3 |
Metabotropic glutamate receptor 2 | 0 | 0 | 1 | 1 |
Metabotropic glutamate receptor 3 | 0 | 0 | 1 | 1 |
Metabotropic glutamate receptor 4 | 0 | 1 | 1 | 2 |
Metabotropic glutamate receptor 5 | 0 | 1 | 2 | 3 |
Metabotropic glutamate receptor 6 | 0 | 0 | 1 | 1 |
Metabotropic glutamate receptor 7 | 0 | 0 | 1 | 1 |
Glutamate receptor ionotropic, kainate 1 | 0 | 1 | 1 | 2 |
Metabotropic glutamate receptor 5 | 0 | 1 | 1 | 3 |
Glutamate receptor ionotropic, kainate 2 | 0 | 2 | 1 | 3 |
Metabotropic glutamate receptor 8 | 0 | 0 | 1 | 1 |
Excitatory amino acid transporter 3 | 0 | 0 | 0 | 1 |
Glutamate racemase | 0 | 0 | 0 | 1 |
Metabotropic glutamate receptor 8 | 0 | 1 | 1 | 2 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, kainate 4 | 0 | 2 | 0 | 2 |
Glutamate carboxypeptidase 2 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, kainate 2 | 0 | 1 | 1 | 2 |
Glutamate receptor ionotropic, kainate 3 | 0 | 1 | 0 | 1 |
Metabotropic glutamate receptor 7 | 0 | 1 | 1 | 3 |
Metabotropic glutamate receptor 3 | 0 | 1 | 1 | 3 |
Metabotropic glutamate receptor 4 | 0 | 1 | 1 | 3 |
Glutamate receptor ionotropic, kainate 5 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, kainate 5 | 0 | 2 | 0 | 2 |
Glutamate racemase | 0 | 0 | 0 | 1 |
Chain A, Glutamine Binding Protein | 0 | 0 | 1 | 1 |
Neutral amino acid transporter A | 0 | 4 | 0 | 4 |
Asc-type amino acid transporter 1 | 0 | 2 | 0 | 2 |
Neutral amino acid transporter B(0) | 0 | 4 | 0 | 4 |
Amino acid transporter | 0 | 4 | 0 | 4 |
ATP-binding cassette sub-family C member 9 | 0 | 1 | 0 | 1 |
Chymotrypsinogen A | 0 | 2 | 0 | 2 |
Beta-lactamase | 0 | 3 | 0 | 3 |
ATP synthase subunit beta, mitochondrial | 0 | 1 | 0 | 1 |
ATP synthase subunit delta, mitochondrial | 0 | 1 | 0 | 1 |
ATP synthase subunit gamma, mitochondrial | 0 | 1 | 0 | 1 |
ATP synthase subunit epsilon, mitochondrial | 0 | 1 | 0 | 1 |
Cystic fibrosis transmembrane conductance regulator | 0 | 1 | 2 | 3 |
Cholesteryl ester transfer protein | 0 | 1 | 0 | 1 |
Peroxisome proliferator-activated receptor gamma | 0 | 4 | 7 | 12 |
Malate dehydrogenase, cytoplasmic | 0 | 1 | 0 | 1 |
ATP-binding cassette sub-family C member 8 | 0 | 2 | 0 | 2 |
ATP-sensitive inward rectifier potassium channel 11 | 0 | 2 | 0 | 2 |
NACHT, LRR and PYD domains-containing protein 3 | 0 | 1 | 0 | 1 |
Mcl-1 | 0 | 2 | 0 | 2 |
Estrogen receptor 1 | 0 | 1 | 0 | 1 |
DNA polymerase III, partial | 3 | 0 | 0 | 3 |
hexokinase-4 isoform 1 | 5 | 0 | 0 | 5 |
atrial natriuretic peptide receptor 1 precursor | 4 | 0 | 0 | 4 |
glucokinase regulatory protein | 5 | 0 | 0 | 5 |
eukaryotic translation initiation factor 4 gamma 1 isoform 4 | 0 | 2 | 0 | 2 |
tyrosine-protein kinase Yes | 2 | 0 | 0 | 2 |
eukaryotic translation initiation factor 4E isoform 1 | 0 | 2 | 0 | 2 |
4-(cytidine 5'-phospho)-2-C-methyl-D-erithritol kinase | 1 | 0 | 0 | 1 |
Prolyl endopeptidase | 0 | 1 | 0 | 1 |
L-lactate dehydrogenase A chain | 0 | 1 | 0 | 1 |
Malate dehydrogenase, mitochondrial | 0 | 1 | 0 | 1 |
L-lactate dehydrogenase B chain | 0 | 1 | 0 | 1 |
Malate dehydrogenase, cytoplasmic | 0 | 1 | 0 | 1 |
L-lactate dehydrogenase B chain | 0 | 1 | 0 | 1 |
DNA-3-methyladenine glycosylase | 0 | 2 | 0 | 2 |
Caspase-1 | 1 | 2 | 0 | 3 |
Kinesin-like protein KIF11 | 0 | 1 | 0 | 1 |
Type 1 InsP3 receptor isoform S2 | 1 | 0 | 0 | 1 |
Peroxisome proliferator-activated receptor alpha | 3 | 3 | 3 | 9 |
L-lactate dehydrogenase | 0 | 1 | 0 | 1 |
Aspartyl/asparaginyl beta-hydroxylase | 0 | 1 | 0 | 1 |
L-lactate dehydrogenase | 0 | 1 | 0 | 1 |
L-lactate dehydrogenase B chain | 0 | 1 | 0 | 1 |
L-lactate dehydrogenase | 0 | 1 | 0 | 1 |
Inosine-5'-monophosphate dehydrogenase | 0 | 1 | 0 | 1 |
Histamine H3 receptor | 1 | 0 | 0 | 1 |
phosphoglycerate kinase | 3 | 0 | 0 | 3 |
2,3-bisphosphoglycerate-independent phosphoglycerate mutase | 2 | 0 | 0 | 2 |
Purine nucleoside phosphorylase | 0 | 2 | 0 | 2 |
Hypoxanthine-guanine phosphoribosyltransferase | 0 | 0 | 0 | 1 |
Ricin | 0 | 1 | 0 | 1 |
2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase | 0 | 0 | 1 | 1 |
Purine nucleoside phosphorylase | 0 | 0 | 1 | 2 |
Shiga toxin subunit A | 0 | 1 | 0 | 1 |
Guanine deaminase | 0 | 1 | 0 | 2 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, Protein (female-specific Histamine Binding Protein 2) | 0 | 0 | 1 | 1 |
aryl hydrocarbon receptor nuclear translocator | 0 | 0 | 0 | 1 |
transforming acidic coiled-coil-containing protein 3 | 0 | 0 | 0 | 1 |
Macrophage migration inhibitory factor | 0 | 3 | 0 | 3 |
Histamine H1 receptor | 0 | 2 | 1 | 3 |
Carbonic anhydrase | 0 | 0 | 0 | 5 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Histamine N-methyltransferase | 0 | 1 | 0 | 1 |
Glutaminyl-peptide cyclotransferase | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 0 | 0 | 5 |
Carbonic anhydrase | 0 | 0 | 0 | 5 |
Carbonic anhydrase | 0 | 0 | 0 | 5 |
Carbonic anhydrase | 0 | 0 | 0 | 5 |
Equilibrative nucleoside transporter 4 | 0 | 0 | 0 | 1 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H4 receptor | 0 | 1 | 0 | 1 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Carboxylic ester hydrolase | 0 | 1 | 0 | 2 |
Chain A, HISTIDINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Histidine-binding periplasmic protein | 0 | 0 | 1 | 1 |
Large neutral amino acids transporter small subunit 1 | 0 | 4 | 0 | 4 |
Uracil nucleotide/cysteinyl leukotriene receptor | 0 | 2 | 0 | 2 |
Chain B, Pulmonary surfactant-associated protein D | 0 | 1 | 0 | 1 |
Chain A, Pulmonary surfactant-associated protein D | 0 | 1 | 0 | 1 |
Sodium/myo-inositol cotransporter 2 | 0 | 1 | 0 | 1 |
NPYLR7B | 0 | 0 | 1 | 1 |
Beta-1 adrenergic receptor | 0 | 0 | 1 | 2 |
Beta-2 adrenergic receptor | 0 | 2 | 2 | 5 |
Beta-1 adrenergic receptor | 0 | 2 | 1 | 3 |
Beta-2 adrenergic receptor | 0 | 2 | 1 | 3 |
Beta-1 adrenergic receptor | 0 | 2 | 1 | 4 |
Beta-2 adrenergic receptor | 0 | 0 | 1 | 1 |
Beta-adrenergic receptor kinase 1 | 0 | 0 | 1 | 1 |
Beta-3 adrenergic receptor | 0 | 0 | 1 | 1 |
Beta-3 adrenergic receptor | 0 | 1 | 1 | 2 |
Vasopressin V1a receptor | 0 | 0 | 1 | 1 |
Beta-1 adrenergic receptor | 0 | 1 | 1 | 2 |
Alpha-1A adrenergic receptor | 0 | 0 | 1 | 1 |
Alpha-1B adrenergic receptor | 0 | 0 | 1 | 1 |
Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
Taste receptor type 2 member 38 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 39 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 40 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 41 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 43 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 31 | 0 | 0 | 2 | 2 |
Taste receptor type 2 member 45 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 46 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 30 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 19 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 20 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 50 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 60 | 0 | 0 | 2 | 2 |
Oxytocin receptor | 0 | 0 | 1 | 1 |
Beta-2 adrenergic receptor | 0 | 1 | 1 | 2 |
Taste receptor type 2 member 42 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 16 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 14 | 0 | 0 | 2 | 3 |
Taste receptor type 2 member 13 | 0 | 0 | 2 | 2 |
Taste receptor type 2 member 10 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 9 | 0 | 0 | 2 | 2 |
Taste receptor type 2 member 8 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 7 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 5 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 4 | 0 | 0 | 2 | 2 |
Taste receptor type 2 member 3 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 1 | 0 | 0 | 1 | 1 |
Fatty acid-binding protein, intestinal | 0 | 1 | 0 | 1 |
Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 2 |
Caspase-3 | 0 | 1 | 0 | 1 |
Caspase-4 | 0 | 1 | 0 | 1 |
Caspase-5 | 0 | 1 | 0 | 1 |
Caspase-9 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A3 | 0 | 1 | 0 | 4 |
Leukotriene B4 receptor 1 | 0 | 2 | 0 | 2 |
Leukotriene B4 receptor 2 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
Type-1 angiotensin II receptor | 0 | 1 | 0 | 1 |
Cocaine esterase | 0 | 1 | 0 | 1 |
DNA topoisomerase 2-alpha | 0 | 1 | 0 | 2 |
Liver carboxylesterase 1 | 0 | 2 | 0 | 2 |
Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
Cytochrome P450 2C11 | 0 | 1 | 0 | 1 |
Ribosyldihydronicotinamide dehydrogenase [quinone] | 0 | 2 | 0 | 2 |
Acetylcholinesterase | 0 | 3 | 0 | 3 |
Mu-type opioid receptor | 0 | 7 | 3 | 13 |
Nociceptin receptor | 0 | 1 | 0 | 1 |
Melatonin receptor type 1C | 0 | 0 | 1 | 1 |
Melatonin receptor type 1A | 0 | 1 | 1 | 2 |
Melatonin receptor type 1C | 0 | 1 | 1 | 2 |
Melatonin receptor type 1B | 0 | 1 | 1 | 2 |
Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 1 | 0 | 1 |
Carboxylic ester hydrolase | 0 | 2 | 0 | 2 |
Chain A, Methionyl-tRNA synthetase | 0 | 0 | 1 | 1 |
Chain A, Methionyl-tRNA synthetase | 0 | 0 | 1 | 1 |
Chain A, Aminopeptidase | 0 | 1 | 0 | 1 |
Chain A, Methionine aminopeptidase | 0 | 1 | 0 | 1 |
S-ribosylhomocysteine lyase | 0 | 1 | 0 | 1 |
Adenylate cyclase type 5 | 0 | 0 | 0 | 1 |
S-adenosylmethionine synthase isoform type-1 | 0 | 0 | 0 | 1 |
S-adenosylmethionine synthase isoform type-2 | 0 | 0 | 0 | 1 |
Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | 0 | 1 | 0 | 1 |
nuclear receptor coactivator 3 isoform a | 0 | 1 | 0 | 1 |
Toll-like receptor 4 | 0 | 1 | 0 | 1 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
ATP-binding cassette sub-family C member 3 | 0 | 1 | 0 | 2 |
Dihydrofolate reductase | 0 | 2 | 0 | 3 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 3 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase ABL1 | 0 | 0 | 1 | 1 |
Thymidylate synthase | 0 | 2 | 0 | 2 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Thymidylate synthase | 0 | 2 | 0 | 3 |
High mobility group protein B1 | 0 | 0 | 2 | 2 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 2 | 4 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Folate receptor beta | 0 | 1 | 0 | 1 |
Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
Folate receptor alpha | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Histidine decarboxylase | 0 | 1 | 2 | 3 |
Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
Cyclin-dependent kinase 2 | 0 | 1 | 1 | 2 |
Bifunctional purine biosynthesis protein ATIC | 0 | 2 | 0 | 2 |
Multidrug resistance-associated protein 1 | 0 | 3 | 1 | 7 |
Delta-type opioid receptor | 0 | 5 | 3 | 9 |
Kappa-type opioid receptor | 0 | 4 | 3 | 8 |
Reduced folate transporter | 0 | 2 | 0 | 2 |
Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 3 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Pteridine reductase 1 | 0 | 1 | 0 | 1 |
Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 3 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Canalicular multispecific organic anion transporter 1 | 0 | 1 | 0 | 2 |
Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
ATP-binding cassette sub-family C member 11 | 0 | 0 | 0 | 1 |
Proton-coupled folate transporter | 0 | 1 | 0 | 1 |
Multidrug resistance associated protein | 0 | 1 | 0 | 2 |
Indoleamine 2,3-dioxygenase 1 | 0 | 3 | 0 | 4 |
Receptor-interacting serine/threonine-protein kinase 1 | 0 | 1 | 1 | 2 |
Nuclear receptor corepressor 1 | 0 | 1 | 0 | 1 |
Integrin beta-1 | 0 | 1 | 0 | 1 |
Integrin alpha-4 | 0 | 1 | 0 | 1 |
Nuclear receptor corepressor 2 | 0 | 1 | 0 | 1 |
pyruvate kinase | 1 | 0 | 0 | 1 |
microphthalmia-associated transcription factor isoform 9 | 0 | 1 | 0 | 1 |
estrogen receptor beta isoform 1 | 0 | 1 | 0 | 1 |
Protein E6 | 0 | 2 | 0 | 2 |
Interstitial collagenase | 0 | 2 | 1 | 3 |
Tubulin beta-4A chain | 0 | 0 | 1 | 1 |
Tubulin beta chain | 0 | 0 | 1 | 1 |
Tyrosine-protein kinase Yes | 0 | 2 | 0 | 2 |
Tubulin alpha-3C chain | 0 | 0 | 1 | 1 |
Islet amyloid polypeptide | 0 | 1 | 0 | 1 |
Low molecular weight phosphotyrosine protein phosphatase | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase SYK | 0 | 3 | 2 | 5 |
Serine/threonine-protein kinase PLK1 | 0 | 2 | 0 | 2 |
Tubulin alpha-1B chain | 0 | 0 | 1 | 1 |
Tubulin alpha-4A chain | 0 | 0 | 1 | 1 |
Tubulin beta-4B chain | 0 | 0 | 1 | 1 |
Receptor-type tyrosine-protein phosphatase S | 0 | 1 | 0 | 1 |
C-terminal-binding protein 1 | 1 | 0 | 0 | 1 |
Tubulin beta-3 chain | 0 | 0 | 1 | 1 |
Tubulin beta-2A chain | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 12 | 0 | 1 | 0 | 1 |
Tubulin beta-8 chain | 0 | 0 | 1 | 1 |
Tubulin alpha-3E chain | 0 | 0 | 1 | 1 |
Tubulin alpha-1A chain | 0 | 0 | 1 | 1 |
Histone-lysine N-methyltransferase SETD7 | 0 | 1 | 0 | 1 |
Aurora kinase B | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 12 | 0 | 2 | 0 | 2 |
Tubulin alpha-1C chain | 0 | 0 | 1 | 1 |
Tubulin beta-6 chain | 0 | 0 | 1 | 1 |
Tubulin beta-2B chain | 0 | 0 | 1 | 1 |
Tubulin beta-1 chain | 0 | 0 | 1 | 1 |
G-protein coupled receptor 35 | 0 | 2 | 2 | 4 |
Class A sortase SrtA | 0 | 1 | 0 | 1 |
Opioid receptor, delta 1b | 0 | 1 | 0 | 1 |
Opioid receptor homologue | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
Acyl-CoA desaturase 1 | 0 | 1 | 0 | 1 |
Translocator protein | 0 | 0 | 1 | 1 |
ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 3 |
Proteinase-activated receptor 1 | 0 | 1 | 1 | 2 |
Sodium-dependent serotonin transporter | 0 | 4 | 0 | 4 |
Delta-type opioid receptor | 0 | 5 | 1 | 9 |
Kappa-type opioid receptor | 0 | 3 | 1 | 7 |
Mu-type opioid receptor | 0 | 3 | 1 | 8 |
Nociceptin receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Mas-related G-protein coupled receptor member X2 | 0 | 0 | 1 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A8 | 0 | 0 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
Cholesteryl ester transfer protein | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-2 | 1 | 0 | 0 | 1 |
D-amino-acid oxidase | 0 | 1 | 0 | 1 |
Hydroxycarboxylic acid receptor 3 | 0 | 0 | 1 | 1 |
Nicotinamidase | 0 | 1 | 0 | 1 |
Hydroxycarboxylic acid receptor 2 | 0 | 0 | 1 | 1 |
Hydroxycarboxylic acid receptor 2 | 0 | 2 | 1 | 3 |
D-aspartate oxidase | 0 | 1 | 0 | 1 |
Hydroxycarboxylic acid receptor 2 | 0 | 1 | 1 | 2 |
Sodium/iodide cotransporter | 0 | 1 | 0 | 1 |
nonstructural protein 1 | 0 | 1 | 0 | 1 |
Nitric oxide synthase, endothelial | 0 | 2 | 0 | 2 |
Nitric oxide synthase, inducible | 0 | 1 | 0 | 1 |
Nitric oxide synthase, brain | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid | 0 | 2 | 0 | 2 |
Alpha-1-acid glycoprotein 1 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 2 | 0 | 2 |
Translocator protein | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 2 | 0 | 2 |
Phosphotyrosine protein phosphatase | 0 | 1 | 0 | 1 |
Hemagglutinin [Cleaved into: Hemagglutinin HA1 chain; Hemagglutinin HA2 chain] | 0 | 0 | 1 | 1 |
Aldo-keto reductase family 1 member B10 | 0 | 2 | 0 | 2 |
Pancreatic alpha-amylase | 0 | 1 | 0 | 3 |
DNA polymerase beta | 0 | 1 | 0 | 1 |
DNA polymerase beta | 0 | 1 | 0 | 1 |
Receptor-type tyrosine-protein phosphatase C | 0 | 1 | 0 | 1 |
Receptor-type tyrosine-protein phosphatase F | 0 | 1 | 0 | 1 |
DNA topoisomerase 1 | 0 | 1 | 0 | 2 |
Receptor-type tyrosine-protein phosphatase alpha | 0 | 1 | 0 | 1 |
Receptor-type tyrosine-protein phosphatase epsilon | 0 | 1 | 0 | 1 |
Low molecular weight phosphotyrosine protein phosphatase | 0 | 1 | 0 | 1 |
Tyrosine-protein phosphatase non-receptor type 6 | 0 | 1 | 0 | 1 |
M-phase inducer phosphatase 2 | 0 | 1 | 0 | 1 |
Signal transducer and activator of transcription 3 | 0 | 2 | 0 | 2 |
Dual specificity protein phosphatase 3 | 0 | 1 | 0 | 1 |
Env polyprotein | 0 | 0 | 1 | 1 |
Rap guanine nucleotide exchange factor 4 | 3 | 0 | 0 | 3 |
NAD-dependent protein deacylase sirtuin-5, mitochondrial | 0 | 1 | 0 | 1 |
Transmembrane prolyl 4-hydroxylase | 0 | 0 | 1 | 1 |
Protease | 0 | 1 | 0 | 1 |
Chain A, Adipocyte Lipid-binding Protein | 0 | 0 | 1 | 1 |
Chain A, MUSCLE FATTY ACID BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain A, MUSCLE FATTY ACID BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain A, MUSCLE FATTY ACID BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain A, BCL-2-RELATED PROTEIN A1 | 0 | 0 | 1 | 1 |
putative potassium channel subunit | 0 | 0 | 1 | 1 |
serine-protein kinase ATM isoform a | 1 | 0 | 0 | 1 |
bcl-2-like protein 11 isoform 1 | 0 | 0 | 1 | 1 |
Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
Fatty acid-binding protein, liver | 0 | 0 | 1 | 1 |
Protein kinase C alpha type | 0 | 0 | 0 | 1 |
Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
Peroxisome proliferator-activated receptor delta | 0 | 3 | 2 | 6 |
Chain A, ARGINASE 1 | 0 | 1 | 0 | 1 |
Chain A, Arginase 1 | 0 | 1 | 0 | 1 |
Chain A, ARGINASE 1 | 0 | 1 | 0 | 1 |
Chain A, L-ARGININE\\:GLYCINE AMIDINOTRANSFERASE | 0 | 1 | 0 | 1 |
Peptidylglycine alpha-amidating monooxygenase | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 2 |
Chain A, cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 1 | 0 | 1 |
cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | 0 | 1 | 0 | 1 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
3',5'-cyclic-AMP phosphodiesterase | 0 | 1 | 0 | 1 |
Vascular endothelial growth factor receptor 1 | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
Serine hydroxymethyltransferase, mitochondrial | 0 | 1 | 0 | 1 |
Vascular endothelial growth factor receptor 3 | 0 | 1 | 0 | 1 |
Vascular endothelial growth factor receptor 2 | 0 | 2 | 0 | 2 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 2 | 0 | 2 |
Phosphodiesterase | 0 | 1 | 0 | 1 |
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 1 | 0 | 2 |
Photosystem I iron-sulfur center | 0 | 0 | 0 | 1 |
Cystathionine gamma-lyase | 0 | 2 | 0 | 2 |
Chain A, Immunoglobulin | 0 | 0 | 1 | 1 |
Chain B, Immunoglobulin | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor M1 | 0 | 0 | 1 | 2 |
Muscarinic acetylcholine receptor M4 | 0 | 0 | 1 | 2 |
Lysosomal Pro-X carboxypeptidase | 0 | 1 | 0 | 1 |
Cholinesterase | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M5 | 0 | 0 | 1 | 2 |
Muscarinic acetylcholine receptor M3 | 0 | 0 | 1 | 2 |
Muscarinic acetylcholine receptor M2 | 0 | 0 | 1 | 2 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Acyl-CoA:cholesterol acyltransferase | 0 | 1 | 0 | 1 |
Chain D, PROTEIN (PHOSPHOGLYCERATE MUTASE 1) | 0 | 1 | 0 | 1 |
Chain A, PROTEIN (PHOSPHOGLYCERATE MUTASE 1) | 0 | 1 | 0 | 1 |
Chain A, Beta-arrestin 1 | 0 | 0 | 1 | 1 |
Sodium/potassium/calcium exchanger 4 | 0 | 1 | 1 | 2 |
Sodium/potassium/calcium exchanger 2 | 0 | 1 | 1 | 2 |
luciferase | 0 | 0 | 0 | 1 |
Glucocorticoid receptor | 0 | 0 | 1 | 1 |
Glycine receptor subunit alpha-1 | 0 | 4 | 0 | 4 |
Glutamine synthetase | 0 | 0 | 1 | 1 |
Glycine receptor subunit beta | 0 | 4 | 0 | 4 |
Glycine receptor subunit alpha-2 | 0 | 4 | 0 | 4 |
Glycine receptor subunit alpha-3 | 0 | 4 | 0 | 4 |
Nociceptin receptor | 0 | 0 | 1 | 1 |
Estrogen receptor beta | 0 | 3 | 1 | 4 |
Glutamate 5-kinase | 0 | 0 | 0 | 1 |
runt-related transcription factor 1 isoform AML1b | 2 | 0 | 0 | 2 |
core-binding factor subunit beta isoform 2 | 2 | 0 | 0 | 2 |
Pyridoxal kinase | 0 | 0 | 0 | 1 |
Monocarboxylate transporter 4 | 0 | 0 | 0 | 1 |
Monocarboxylate transporter 2 | 0 | 0 | 0 | 1 |
Monocarboxylate transporter 1 | 0 | 1 | 0 | 2 |
C-terminal-binding protein 2 | 0 | 1 | 0 | 1 |
Monocarboxylate transporter 2 | 0 | 2 | 0 | 2 |
Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
Chain A, APH(2')-Id | 0 | 1 | 0 | 1 |
glucose-6-phosphate dehydrogenase | 0 | 1 | 0 | 1 |
signal transducer and activator of transcription 6, interleukin-4 induced | 1 | 0 | 0 | 1 |
hexokinase | 0 | 2 | 0 | 2 |
Maltase-glucoamylase, intestinal | 0 | 1 | 0 | 1 |
NUAK family SNF1-like kinase 1 | 0 | 1 | 0 | 1 |
B2 bradykinin receptor | 0 | 1 | 0 | 1 |
Prothrombin | 0 | 1 | 0 | 1 |
Chymotrypsin-like elastase family member 1 | 0 | 1 | 0 | 1 |
Neuraminidase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Glycogen phosphorylase, liver form | 0 | 1 | 0 | 1 |
Epoxide hydrolase 1 | 0 | 1 | 0 | 1 |
Proto-oncogene tyrosine-protein kinase receptor Ret | 0 | 1 | 0 | 1 |
Insulin-like growth factor 1 receptor | 0 | 1 | 0 | 1 |
Stromelysin-1 | 0 | 2 | 1 | 3 |
Heterogeneous nuclear ribonucleoprotein A1 | 0 | 0 | 1 | 1 |
Lysosomal alpha-glucosidase | 0 | 1 | 0 | 1 |
Sialidase | 0 | 1 | 0 | 1 |
Malate dehydrogenase | 0 | 1 | 0 | 1 |
Cytochrome P450 2C8 | 0 | 2 | 0 | 2 |
Solute carrier family 2, facilitated glucose transporter member 2 | 0 | 1 | 0 | 1 |
Cyclin-dependent kinase 4 | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
Sucrase-isomaltase, intestinal | 0 | 1 | 0 | 1 |
Matrix metalloproteinase-9 | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase B-raf | 0 | 1 | 0 | 1 |
Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
Chymotrypsinogen B | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX12 | 0 | 1 | 0 | 1 |
Solute carrier family 2, facilitated glucose transporter member 4 | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
G1/S-specific cyclin-D1 | 0 | 1 | 0 | 1 |
C-X-C chemokine receptor type 1 | 0 | 1 | 0 | 1 |
Phosphatidylinositol 3-kinase regulatory subunit alpha | 0 | 1 | 0 | 1 |
Cytosol aminopeptidase | 0 | 1 | 0 | 1 |
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase receptor UFO | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
RAC-alpha serine/threonine-protein kinase | 0 | 1 | 0 | 1 |
Bifunctional epoxide hydrolase 2 | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Macrophage metalloelastase | 0 | 1 | 0 | 1 |
Glutathione reductase | 0 | 1 | 0 | 1 |
Collagenase 3 | 0 | 1 | 0 | 1 |
1-deoxy-D-xylulose 5-phosphate reductoisomerase | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
Prolyl endopeptidase | 0 | 1 | 0 | 1 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
C-C chemokine receptor type 4 | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase Nek2 | 0 | 1 | 0 | 1 |
Oligo-1,6-glucosidase IMA1 | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
Anthrax toxin receptor 2 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Heat shock factor protein 1 | 0 | 1 | 0 | 1 |
cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
Dual specificity mitogen-activated protein kinase kinase 1 | 0 | 1 | 0 | 1 |
Focal adhesion kinase 1 | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent protein kinase type II subunit beta | 0 | 1 | 0 | 1 |
ELAV-like protein 3 | 0 | 1 | 0 | 1 |
ELAV-like protein 1 | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase N1 | 0 | 1 | 0 | 1 |
Probable maltase-glucoamylase 2 | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Inositol polyphosphate multikinase | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member C21 | 0 | 2 | 0 | 2 |
Chymotrypsin-C | 0 | 1 | 0 | 1 |
Phosphodiesterase | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase Nek6 | 0 | 1 | 0 | 1 |
NADPH oxidase 4 | 0 | 1 | 0 | 1 |
Inositol hexakisphosphate kinase 2 | 0 | 1 | 0 | 1 |
Short transient receptor potential channel 5 | 0 | 1 | 0 | 1 |
Lysine-specific demethylase 4E | 0 | 1 | 0 | 1 |
Advanced glycosylation end product-specific receptor | 0 | 0 | 1 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Advanced glycosylation end product-specific receptor | 0 | 0 | 1 | 1 |
Chain A, PLASMA RETINOL-BINDING PROTEIN PRECURSOR | 0 | 0 | 1 | 1 |
Retinol-binding protein 4 | 0 | 0 | 1 | 1 |
Beta-lactoglobulin | 0 | 0 | 1 | 1 |
CDGSH iron-sulfur domain-containing protein 1 | 0 | 1 | 0 | 1 |
Free fatty acid receptor 1 | 0 | 0 | 1 | 1 |
Carnitine O-palmitoyltransferase 2, mitochondrial | 0 | 1 | 0 | 1 |
Cytochrome P450 3A5 | 0 | 0 | 1 | 1 |
Catechol O-methyltransferase | 0 | 0 | 1 | 1 |
Peroxisome proliferator-activated receptor alpha | 0 | 1 | 2 | 3 |
Carnitine O-palmitoyltransferase 2, mitochondrial | 0 | 1 | 0 | 1 |
Thromboxane-A synthase | 0 | 1 | 0 | 1 |
Peroxisome proliferator-activated receptor gamma | 0 | 0 | 2 | 2 |
C-C chemokine receptor type 2 | 0 | 1 | 0 | 1 |
Carnitine O-palmitoyltransferase 1, liver isoform | 0 | 1 | 0 | 1 |
Thrombin | 0 | 0 | 1 | 1 |
CDGSH iron-sulfur domain-containing protein 2 | 0 | 1 | 0 | 1 |
NADH-ubiquinone oxidoreductase chain 1 | 0 | 1 | 0 | 1 |
NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial | 0 | 1 | 0 | 1 |
Dihydroorotate dehydrogenase (fumarate) | 0 | 1 | 0 | 1 |
Acyl carrier protein, mitochondrial | 0 | 1 | 0 | 1 |
Dihydroorotate dehydrogenase | 0 | 1 | 0 | 1 |
Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
Chain A, 146aa long hypothetical transcriptional regulator | 0 | 0 | 1 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain B, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain C, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Estrogen receptor beta | 0 | 0 | 0 | 1 |
Inhibitor of nuclear factor kappa-B kinase subunit beta | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase subunit beta-2 | 0 | 0 | 0 | 1 |
Tyrosine-protein phosphatase YopH | 0 | 1 | 0 | 1 |
Estrogen receptor | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-1 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase catalytic subunit alpha-2 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase catalytic subunit alpha-1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Ubiquitin-like domain-containing CTD phosphatase 1 | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-3 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-2 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase subunit beta-1 | 0 | 0 | 0 | 1 |
Pyruvate kinase PKM | 0 | 0 | 1 | 1 |
Chain A, Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
Chain A, Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
Thromboxane A2 receptor | 0 | 0 | 0 | 1 |
Peroxisome proliferator-activated receptor delta | 0 | 0 | 1 | 1 |
Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 2 | 0 | 3 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 2 |
Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 4 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 4 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 3 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 4 | 0 | 0 | 0 | 1 |
Nuclear factor NF-kappa-B p100 subunit | 0 | 1 | 0 | 1 |
Chain A, ykoF | 0 | 0 | 1 | 1 |
Chain B, ykoF | 0 | 0 | 1 | 1 |
Chain A, ThiT | 0 | 0 | 1 | 1 |
Thiamine transporter ThiT | 0 | 0 | 1 | 1 |
Transketolase | 0 | 0 | 1 | 1 |
Thiamine-binding periplasmic protein | 0 | 0 | 1 | 1 |
Ubiquitin-like modifier activating enzyme 2 | 0 | 1 | 0 | 1 |
SUMO1 activating enzyme subunit 1 | 0 | 1 | 0 | 1 |
SUMO-conjugating enzyme UBC9 | 0 | 1 | 0 | 1 |
Vif | 0 | 1 | 0 | 1 |
Tat | 0 | 1 | 0 | 1 |
bifunctional UDP-N-acetylglucosamine pyrophosphorylase/glucosamine-1-phosphate N-acetyltransferase | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 1 | 0 | 2 |
Thymidine kinase | 0 | 1 | 0 | 2 |
Thymidine phosphorylase | 0 | 0 | 0 | 1 |
Thymidylate kinase | 0 | 1 | 0 | 1 |
Thymidine kinase, cytosolic | 0 | 0 | 0 | 2 |
Thymidine kinase | 0 | 0 | 0 | 1 |
Thymidylate kinase | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 1 | 0 | 2 |
Thymidine kinase | 0 | 0 | 0 | 1 |
Thymidine kinase | 0 | 0 | 0 | 1 |
Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 2 | 2 |
Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 2 | 2 |
Solute carrier organic anion transporter family member 1A4 | 0 | 1 | 0 | 3 |
Thyroid hormone receptor alpha | 0 | 2 | 3 | 5 |
Thyroid hormone receptor beta | 0 | 2 | 3 | 5 |
Proliferating cell nuclear antigen | 0 | 2 | 0 | 2 |
Malate dehydrogenase, mitochondrial | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A2 | 0 | 0 | 0 | 2 |
Solute carrier organic anion transporter family member 4C1 | 0 | 1 | 0 | 2 |
Monocarboxylate transporter 8 | 0 | 0 | 0 | 1 |
Bile acid receptor | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1C1 | 0 | 0 | 0 | 1 |
HLA class I histocompatibility antigen, A alpha chain | 0 | 0 | 1 | 1 |
Chain A, X-ray structure of the sucrose-phosphatase (SPP) from Synechocystis sp.PCC6803 in complex with trehalose | 0 | 1 | 0 | 1 |
Chain A, X-ray structure of the sucrose-phosphatase (SPP) from Synechocystis sp.PCC6803 in complex with cellobiose | 0 | 1 | 0 | 1 |
Chain A, X-ray structure of the sucrose-phosphatase (SPP) from Synechocystis sp.PCC6803 in complex with maltose | 0 | 1 | 0 | 1 |
Trehalose-phosphatase | 0 | 1 | 0 | 1 |
Chain A, Nuclear Receptor ROR-beta | 0 | 1 | 0 | 1 |
Ornithine decarboxylase | 0 | 0 | 0 | 1 |
Ornithine decarboxylase | 0 | 0 | 0 | 1 |
Retinoic acid receptor alpha | 0 | 2 | 2 | 7 |
Retinoic acid receptor beta | 0 | 2 | 2 | 7 |
Retinoic acid receptor alpha | 0 | 1 | 2 | 3 |
Retinoic acid receptor gamma | 0 | 2 | 2 | 7 |
Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
Retinoic acid receptor gamma | 0 | 1 | 2 | 3 |
Retinoic acid receptor beta | 0 | 1 | 2 | 3 |
Cellular retinoic acid-binding protein 2 | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase 1 | 0 | 1 | 0 | 1 |
Retinoic acid receptor RXR-alpha | 0 | 1 | 2 | 3 |
Retinoic acid receptor RXR-beta | 0 | 2 | 2 | 4 |
Retinoic acid receptor RXR-beta | 0 | 1 | 2 | 3 |
Retinoic acid receptor RXR-gamma | 0 | 1 | 2 | 3 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-alpha | 0 | 1 | 0 | 1 |
Cellular retinoic acid-binding protein 1 | 0 | 1 | 0 | 2 |
Retinoic acid receptor RXR-gamma | 0 | 2 | 2 | 4 |
Cellular retinoic acid-binding protein 1 | 0 | 0 | 1 | 1 |
Indoleamine 2,3-dioxygenase 2 | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-beta | 0 | 1 | 0 | 1 |
Thyroid hormone receptor beta | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 4A1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1C1 | 0 | 1 | 0 | 1 |
Chain A, Trp Rna-binding Attenuation Protein | 0 | 0 | 1 | 1 |
Chain K, Trp Rna-binding Attenuation Protein | 0 | 0 | 1 | 1 |
Chain B, tryptophanyl-tRNA synthetase | 0 | 0 | 1 | 1 |
Chain C, Tryptophanyl-tRNA synthetase II | 0 | 0 | 1 | 1 |
Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 1 | 0 | 1 |
Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
Tryptophan 2,3-dioxygenase | 0 | 1 | 0 | 2 |
SLC16A10 protein | 0 | 0 | 0 | 2 |
Tryprostatin B synthase | 0 | 0 | 0 | 1 |
2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase | 0 | 0 | 1 | 1 |
Monocarboxylate transporter 10 | 0 | 0 | 0 | 2 |
Phospholipase A-2-activating protein | 0 | 1 | 0 | 1 |
Chain A, CHORISMATE MUTASE | 0 | 1 | 0 | 1 |
Chain A, TYROSYL-tRNA SYNTHETASE | 0 | 0 | 1 | 1 |
Tubulin--tyrosine ligase | 0 | 1 | 0 | 1 |
Cadherin-1 | 0 | 1 | 0 | 1 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
Adenomatous polyposis coli protein | 0 | 1 | 0 | 1 |
Catenin beta-1 | 0 | 2 | 0 | 2 |
Transcription factor 7-like 2 | 0 | 1 | 0 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Solute carrier family 2, facilitated glucose transporter member 9 | 0 | 1 | 1 | 2 |
Chain A, Cytidine Deaminase | 0 | 1 | 0 | 1 |
Sodium/nucleoside cotransporter 1 | 0 | 2 | 0 | 2 |
Sodium/nucleoside cotransporter 2 | 0 | 2 | 0 | 2 |
Cytidine deaminase | 0 | 1 | 0 | 1 |
Equilibrative nucleoside transporter 2 | 0 | 2 | 0 | 2 |
Protein cereblon | 0 | 2 | 0 | 2 |
Equilibrative nucleoside transporter 1 | 0 | 2 | 0 | 2 |
Uridine-cytidine kinase 1 | 0 | 0 | 0 | 1 |
Solute carrier family 28 member 3 | 0 | 2 | 0 | 2 |
Glycoprotein | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 0 | 1 | 1 |
Catechol O-methyltransferase | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 3 | 0 | 1 | 0 | 1 |
Chloroquine resistance transporter | 0 | 1 | 0 | 1 |
MO15-related protein kinase Pfmrk | 0 | 1 | 0 | 1 |
Myosin light chain kinase, smooth muscle | 0 | 1 | 0 | 1 |
Proprotein convertase subtilisin/kexin type 7 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1 | 0 | 1 | 0 | 1 |
Protease | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1 | 0 | 2 | 0 | 2 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |